fluorodeoxyglucose f18 has been researched along with Cognition Disorders in 272 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (1.10) | 18.7374 |
1990's | 10 (3.68) | 18.2507 |
2000's | 99 (36.40) | 29.6817 |
2010's | 156 (57.35) | 24.3611 |
2020's | 4 (1.47) | 2.80 |
Authors | Studies |
---|---|
Camacho, V; Horta-Barba, A; Kulisevsky, J; Martinez-Horta, S; Pagonabarraga, J; Pérez-Pérez, J; Sampedro, F | 1 |
Alshammari, M; Alshammari, T; Bergendal, Å; Di Re, J; Granberg, T; Iwarsson, E; Laezza, F; Lindefeldt, M; Lundin, J; Paucar, M; Savitcheva, I; Solders, G; Svenningsson, P | 1 |
Bombois, S; Boullet, A; Bruneteau, G; Delorme, C; Demeret, S; Doukhi, D; Fossati, P; Godefroy, N; Hesters, A; Kas, A; Le Guennec, L; Maatoug, R; Millet, B; Navarro, V; Paccoud, O; Pourcher, V; Shambrook, P | 1 |
De Vincentis, G; Frantellizzi, V; Madeddu, G; Nuvoli, S; Palumbo, B; Spanu, A; Stazza, ML; Tanda, G | 1 |
Alexopoulos, P; Perneczky, R; Robb, C; Schöpe, J; Udeh-Momoh, C; Wagenpfeil, S | 1 |
Asano, Y; Shinoda, J | 1 |
Claassen, DO; Samson, M | 1 |
Buschmann, F; Frings, L; Metternich, B; Meyer, PT; Ofer, I; Schulze-Bonhage, A; Spehl, TS; Trippel, M; Urbach, H; Wagner, K | 1 |
Dillen, KNH; Fink, GR; Jacobs, HIL; Kukolja, J; Langen, KJ; Onur, ÖA; Richter, N; von Reutern, B | 1 |
Bertani, GA; Bertulli, L; Gianelli, U; Locatelli, M; Mantovani, G; Rampini, PM | 1 |
Fanale, CM; Melrose, RJ; Sultzer, DL; Veliz, JV; Weissberger, GH | 1 |
Andrews, RD; Brewer, J; Lukic, AS; Matthews, DC; Mobley, WC; Ness, S; Pennington, C; Rafii, MS; Rissman, RA; Strother, SC; Wernick, MN | 1 |
Annarumma, I; Brunetti, A; De Lucia, N; De Michele, G; De Rosa, A; Esposito, M; Manganelli, F; Pappatà, S; Peluso, S; Russo, P | 1 |
Charidimou, A; Pasi, M; Viswanathan, A; Xiong, L | 1 |
Ances, BM; Bateman, R; Benzinger, TLS; Buckles, VD; Cairns, NJ; Chhatwal, JP; Danek, A; Farlow, MR; Galasko, DR; Ghetti, B; Hedden, T; Jack, C; Jaimes, S; Johnson, KA; Kinnunen, KM; Koeppe, RA; Laske, C; Levin, J; Marcus, DS; Martins, RN; Masters, CL; McDade, E; Morris, JC; Ringman, JM; Salloway, S; Schofield, PR; Schultz, AP; Sperling, RA; Xiong, C; Yakushev, I | 1 |
Bergendal, Å; Gustavsson, P; Laffita-Mesa, J; Nordenskjöld, M; Paucar, M; Savitcheva, I; Svenningsson, P | 1 |
Guilleminault, C; Hsiao, IT; Huang, WC; Huang, YS; Hwang, FM; Lin, KL; Liu, FY | 1 |
Camacho, V; Carceller-Sindreu, M; Carrió, I; Fernández-León, A; Gomez-Anson, B; Horta-Barba, A; Kulisevsky, J; Lopez-Mora, DA; Lozano-Martinez, GA; Martínez-Horta, S; Pagonabarraga, J; Perez-Perez, J; Sampedro, F | 1 |
Abrunhosa, A; Barroca, D; Cardoso, E; Castelo-Branco, M; Cruz, Â; de Mendonça, A; Moreira, AP; Oliveira, FPM; Rio, J; Verdelho, A; Xavier, C | 1 |
Brammer, M; de Paula, JJ; de Souza Costa, D; Malamut, C; Malloy-Diniz, LF; Mamede, M; Miranda, DM; Romano-Silva, MA; Schütze, M | 1 |
Boellaard, R; De Deyn, PP; de Jong, BM; Dierckx, RA; García, DV; Huitema, RB; Meles, SK; Peretti, DE; Reesink, FE; Sánchez-Catasús, CA; Willemsen, AT | 1 |
Dey, AK; Geannopoulos, K; Hammoud, DA; Mehta, NN; Nath, A; Rapoport, SI; Sinharay, S; Smith, BR; Snow, J; Steinbach, S; Traino, K; Tramont, E; Wakim, PG | 1 |
Baroni, L; Dell'Acqua, C; Di Battista, ME; Fenoglio, C; Galimberti, D; Gallucci, M | 1 |
Jagust, WJ; Landau, SM; Markley, C; Mormino, EC; Oh, H; Wirth, M | 1 |
Chen, S; Cheng, B; Kaufer, DI; Shen, D; Zhang, D | 1 |
Blum, K; Braverman, ER; Damle, UJ; Dushaj, K; Kerner, M; Oscar-Berman, M | 1 |
Jagust, WJ; Landau, SM; Madison, CM; Oh, H; Rabinovici, GD; Wirth, M | 1 |
Aeinehband, S; Almkvist, O; Darreh-Shori, T; Ekdahl, KN; Långström, B; Lindblom, RP; Nilsson, B; Nordberg, A; Piehl, F; Vijayaraghavan, S | 1 |
Duffy, JR; Gunter, JL; Jack, CR; Josephs, KA; Kantarci, K; Lowe, VJ; Machulda, MM; Murphy, MC; Senjem, ML; Strand, EA; Whitwell, JL; Wille, SM | 1 |
Chung, SJ; Im, KC; Kim, J; Kim, JS; Kim, MJ; Lee, JH; Lee, MC; Park, HK | 1 |
Ahlskog, JE; Clark, HM; Duffy, JR; Josephs, KA; Sorenson, EJ; Whitwell, JL | 1 |
Adeli, A; Drubach, DA; Machulda, MM | 1 |
Gregg, BE; Gunter, JL; Jack, CR; Jones, DT; Knopman, DS; Lowe, V; Mielke, MM; Pankratz, VS; Petersen, RC; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
Haase, CM; Jagust, WJ; Landau, SM; Madison, CM; Oh, H; Rabinovici, GD; Villeneuve, S; Wirth, M | 1 |
Amtage, F; Bormann, T; Frings, L; Hellwig, S; Kreft, A; Meyer, PT; Spehl, TS; Tüscher, O; Weiller, C | 1 |
Banzo, I; Carril, JM; de Arcocha-Torres, M; Ibañez-Bravo, S; Jiménez-Bonilla, J; Martínez-Amador, N; Martínez-Rodríguez, I; Ortega-Nava, F; Quirce, R; Rodríguez, E; Sánchez, PJ; Vázquez, JL | 1 |
Chen, Z; Hao, Y; Tang, Z; Zeng, X; Zhai, Q; Zhang, Y | 1 |
Boxer, AL; Gesierich, B; Ghosh, PM; Gorno-Tempini, M; Grinberg, LT; Hagen, J; Henry, M; Huang, EJ; Jagust, WJ; Janabi, M; Kramer, JH; Miller, BL; O'Neil, JP; Rabinovici, GD; Rosen, HJ; Sánchez-Juan, P; Seeley, WW; Trojanowski, JQ; Vinters, HV | 1 |
Ding, Y; Hu, XY; Jiang, XF; Nie, BB; Sy, C; Zhang, T | 1 |
Arima, K; Imabayashi, E; Ito, K; Matsuda, H; Nakata, Y; Omachi, Y; Sato, N; Shimano, Y | 1 |
Herben-Dekker, M; Jurgens, CK; Kremer, HP; Leenders, KL; Roos, RA; Spikman, JM; van Oostrom, JC; Witjes-Ané, MN | 1 |
Cavaliere, C; Colucci, L; Fasanaro, AM; Molino, I; Quarantelli, M; Salvatore, E | 1 |
Albin, RL; Dodge, HH; Harvey, D; Kaye, JA; Koeppe, RA; Saito, N; Silbert, LC; Zhu, J | 1 |
Acion, L; Ariza, MJ; Berthier, ML; García-Arnés, JA; García-Casares, N; Gonzalez-Alegre, P; González-Santos, P; Gutiérrez, A; Jorge, RE; Nabrozidis, A; Rioja, J | 1 |
Gnanavel, S | 1 |
de Vries, JJ; Dierckx, RA; Izaks, GJ; Leenders, KL; Renken, RJ; Roerdink, JB; Segbers, M; Strijkert, F; Teune, LK | 1 |
Armstrong, GT; Brinkman, TM; Edelmann, M; Hudson, MM; Krull, KR; Minoshima, S; Morris, B; Robison, LL; Sabin, ND; Shulkin, B | 1 |
Aarsland, D; Auning, E; Bjørnerud, A; Fladby, T; Grambaite, R; Haram, A; Hessen, E; Hol, PK; Løvli Stav, A; Muftuler løndalen, A; Šaltytė Benth, J; Selnes, P | 1 |
Capriotti, G; Pagani, M; Sonni, I | 1 |
Blennow, K; Donohue, M; Insel, PS; Jagust, WJ; Landau, S; Mattsson, N; Shaw, LM; Trojanowski, JQ; Weiner, MW; Zetterberg, H | 1 |
Cabrera-Martín, MN; Carreras, JL; Fernandez-Matarrubia, M; Matías-Guiu, J; Matías-Guiu, JA; Moreno-Ramos, T; Valles-Salgado, M | 1 |
Danion, JM; Foucher, J; Gorse, A; Jantzi, C; Lalanne, L; Zimmermann, MA | 1 |
Hattori, N; Hirata, K; Kobayashi, K; Manabe, O; Morimoto, Y; Okamoto, S; Shiga, T; Takeuchi, W; Tamaki, N; Umegaki, K | 1 |
Beer, AJ; Riepe, MW; Vonend, C; Walther, B | 1 |
Chen, K; Foster, NL; Jagust, WJ; Koeppe, RA; Landau, SM; Mathis, CA; Price, JC; Reiman, EM; Wang, AY | 1 |
Asthana, S; Bendlin, BB; Birdsill, AC; Christian, BT; Hermann, BP; Johnson, SC; Jonaitis, EM; Koscik, RL; La Rue, A; Okonkwo, OC; Sager, MA; Starks, EJ; Willette, AA | 1 |
Ahn, SW; Bae, JH; Jeong, HB; Kim, JM; Kwon, OS; Park, MS; Youn, YC | 1 |
Fujiwara, S; Kobayashi, M; Ogasawara, K; Ogawa, A; Saito, H; Saura, H; Terasaki, K; Yoshida, K | 1 |
Bormann, T; Buchert, R; Frings, L; Heimbach, B; Hellwig, S; Klöppel, S; Meyer, PT; Minkova, L; Spehl, TS; Vach, W | 1 |
Bunai, T; Hosoi, Y; Kakimoto, A; Konishi, T; Kono, S; Miyajima, H; Ouchi, Y; Sakao-Suzuki, M; Terada, T; Yoshikawa, E | 1 |
Defebvre, L; Delval, A; Demailly, F; Dujardin, K; Moreau, C; Semah, F; Tard, C | 1 |
Benoit, M; Bensamoun, D; Darcourt, J; David, R; Derreumaux, A; Furst, AJ; Guignard, R; Manera, V; Robert, PH | 1 |
Calvo, A; Cammarosano, S; Canosa, A; Chiò, A; Cistaro, A; Fania, P; Iazzolino, B; Ilardi, A; Moglia, C; Montuschi, A; Pagani, M | 1 |
Barbarulo, AM; Califano, F; Coppola, C; Di Fede, G; Di Iorio, G; Piccoli, E; Rossi, G; Saracino, D; Tagliavini, F | 1 |
Gámez, C; Gascon-Bayarri, J; Paipa, A; Povedano, M; Reñé, R; Rico, I; Turon-Sans, J | 1 |
Chen, JG; Huang, JG; Jiang, FC; Liang, X; Liu, JM; Long, LH; Luo, H; Rao, J; Shen, ZC; Wang, F; Wu, PF; Xie, QG; Zhou, J | 1 |
Chen, HJ; Ding, J; Jiang, SM; Li, TN; Tong, Q; Wang, JW; Wang, M; Xu, QR; Yuan, YS; Zhang, KZ; Zhang, L | 1 |
Kim, YW; Lee, JK; Lee, S; Lim, OK; Park, KD; Park, Y; Yoo, CJ | 1 |
Aisen, PS; Boustani, M; Crane, PK; Farlow, MR; Gao, S; Jack, CR; Jagust, WJ; McDonald, BC; Petersen, RC; Risacher, SL; Saykin, AJ; Tallman, EF; Unverzagt, FW; Weiner, MW; West, JD | 1 |
Apostolova, I; Buchert, R; Fiebach, JB; Lange, C; Mäurer, A; Ritter, K; Seybold, J; Spies, L; Steinhagen-Thiessen, E | 1 |
Bertolotto, A; Cavalla, P; Chiavazza, C; Cistaro, A; Fania, P; Pinessi, L; Rudà, R; Soffietti, R | 1 |
Brandel, JP; Brefel Courbon, C; Dumas, H; Guedj, E; Lesage, S; Ory Magne, F; Pariente, J; Payoux, P; Peoc'h, K; Puel, M; Saint-Aubert, L; Vital, A | 1 |
Joung, HY; Kim, JS; Lim, I; Shim, I; Yu, AR | 1 |
Andreasson, U; Baker, D; Blennow, K; Hanlon, D; Hansson, O; Insel, PS; Janelidze, S; Jeromin, A; Mattsson, N; Palmqvist, S; Shaw, LM; Song, L; Stomrud, E; Tan Hehir, CA; Trojanowski, JQ; Weiner, MW; Zetterberg, H | 1 |
Biegon, A; Landau, S; Lipton, RB; Maki, PM; Rubin, LH; Sundermann, EE | 1 |
Brandt, V; Dhawan, V; Eidelberg, D; Gordon, ML; Mattis, PJ; Nazem, A; Niethammer, M; Sako, W; Tang, CC | 1 |
Abulizi, M; Aouizerate, J; Aoun Sebaiti, M; Authier, FJ; Bachoud-Levi, AC; Chalaye, J; Cottereau, AS; Evangelista, E; Gherardi, RK; Guedj, E; Itti, E; Van Der Gucht, A; Verger, A; Yara, S | 1 |
Benarroch, EE; Golden, EC; Graff-Radford, J; Jones, DT | 1 |
Bischof, GN; Dronse, J; Drzezga, A; Faber, J; Fink, GR; Fliessbach, K; Hammes, J; Jessen, F; Klockgether, T; Kuhnert, G; Kukolja, J; Neumaier, B; Onur, OA; van Eimeren, T; von Reutern, B | 1 |
Apostolova, I; Buchert, R; Estrella, M; Igel, HJ; Lämmler, G; Lange, C; Liese, S; Mäurer, A; Prasad, V; Roberts, A; Stechl, E; Steinhagen-Thiessen, E | 1 |
Aoki, M; Baba, T; Hasegawa, T; Hirayama, K; Hosokai, Y; Kikuchi, A; Mori, E; Nishio, Y; Suzuki, K; Takeda, A | 1 |
Aigbirhio, FI; Allinson, KS; Arnold, R; Bevan-Jones, WR; Borchert, RJ; Cope, TE; Fryer, TD; Hong, YT; Jones, PS; Mak, E; O'Brien, JT; Passamonti, L; Rowe, JB; Sami, S; Su, L; Surendranathan, A; Vázquez Rodríguez, P; Williamson, D | 1 |
Dichgans, M; Duering, M; Ewers, M; Franzmeier, N; Weiner, M | 1 |
Alegret, M; Assal, F; Austin, M; Balasa, M; Bastin, C; Bocchetta, M; Bosco, P; Bougea, A; Chincarini, A; Collins, DL; Duchesne, S; Emek-Savaş, DD; Engelborghs, S; Ferrari, C; Frisoni, GB; Galluzzi, S; Grimmer, T; Grosu, G; Kramberger, MG; Lawlor, B; Mandic Stojmenovic, G; Maréchal, B; Marinescu, M; Mecocci, P; Mega, A; Molinuevo, JL; Morais, R; Niemantsverdriet, E; Nobili, F; Ntovas, K; O'Dwyer, S; Paraskevas, GP; Pelini, L; Picco, A; Popovic, KS; Redolfi, A; Roche, A; Salmon, E; Santana, I; Sensi, F; Sotolongo-Grau, O; Spiru, L; Stefanova, E; Tsolaki, M; Wolz, R; Yener, GG; Zekry, D | 1 |
de Leon, MJ; DeSanti, S; Kemppainen, N; Kim, BC; Li, Y; Mosconi, L; Någren, K; Pirraglia, E; Rinne, JO; Rusinek, H; Tsui, W | 1 |
Bartenstein, P; Buchholz, HG; Fellgiebel, A; Hammers, A; Lieb, K; Peters, J; Scheurich, A; Schmidtmann, I; Schreckenberger, M; Yakushev, I | 1 |
Hahn, CA; Hollis, D; Kirkpatrick, J; Light, K; Marks, LB; Raynor, R; Shafman, T; Tisch, A; Turkington, T; Wong, T; Zhou, SM | 1 |
Bruno, G; Lenzi, GL; Talarico, G; Tosto, G | 1 |
Brewer, J; Dale, AM; Fennema-Notestine, C; Fjell, AM; Karow, DS; McEvoy, LK; Salmon, DP; Walhovd, KB | 1 |
Bartenstein, P; Buchholz, HG; Fellgiebel, A; Gerhard, A; Hammers, A; Landvogt, C; Scheurich, A; Schmidtmann, I; Schreckenberger, M; Yakushev, I | 1 |
Borroni, B; Cappa, SF; Fazio, F; Garibotto, V; Herholz, K; Holtoff, V; Kalbe, E; Padovani, A; Perani, D; Salmon, E; Sorbi, S | 1 |
Peskind, ER | 1 |
Gu, ZX; Wei, WS; Yuan, Y | 1 |
Coppola, C; Cotrufo, R; Di Fede, G; Formisano, S; Giaccone, G; Lavorgna, A; Leonardi, A; Mauro, C; Nigro, M; Piscosquito, G; Puoti, G; Tagliavini, F | 1 |
Andermann, F; Bebek, N; Gokyigit, A; Gurses, C; Kinay, D; Vanli, E | 1 |
Dinh, HD; Fukuyama, H; Hashikawa, K; Ishizu, K; Namiki, C; Nishi, H; Sawamoto, N; Yoshida, H | 1 |
Chin, J; Cho, SS; Na, DL; Park, A; Seo, SW | 1 |
Barrio, JR; Bookheimer, SY; Ercoli, LM; Huang, SC; Lavretsky, H; Miller, KJ; Phelps, ME; Siddarth, P; Silverman, DH; Small, GW | 1 |
Ishii, H; Ishikawa, H; Meguro, K; Tashiro, M; Yamaguchi, S | 1 |
de Leon, MJ; De Santi, S; Glodzik, L; Li, Y; Mistur, R; Mosconi, L; Pirraglia, E; Reisberg, B; Switalski, R; Tsui, WH; Wisniewski, T | 1 |
Fukuda, H; Hirayama, K; Hosokai, Y; Ishioka, T; Itoyama, Y; Mori, E; Nishio, Y; Sawada, Y; Suzuki, K; Takahashi, S; Takeda, A | 1 |
Bertran, F; Clochon, P; Denise, P; Desgranges, B; Eustache, F; Foret, J; Mézenge, F; Yaouhi, K | 1 |
Alexander, GE; Bandy, D; Chen, K; Fleisher, AS; Foster, NL; Jagust, WJ; Koeppe, RA; Langbaum, JB; Lee, W; Reiman, EM; Reschke, C; Weiner, MW | 1 |
Ahn, BC; Kim, YT; Kwon, DH; Lee, J; Lee, SW; Seo, JH | 1 |
Boeve, B; Jack, CR; Kemp, BJ; Knopman, D; Lowe, VJ; Mullan, B; Petersen, RC; Senjem, M; Shiung, M; Smith, G; Weigand, S | 1 |
Baron, JC; Chételat, G; de la Sayette, V; Desgranges, B; Duchesnay, E; Eustache, F; Fouquet, M; Landeau, B; Mézenge, F; Viader, F | 1 |
Berg, D; Gaenslen, A; Godau, J; Herbst, H; Liepelt, I; Maetzler, W; Reimold, M; Reischl, G | 1 |
Attems, J; Booij, J; Bruecke, T; Dimou, E; Dudczak, R; Knoll, P; Kuntner, C; Langer, O; Mirzaei, S; Mostbeck, G; Prosch, H; Rodrigues, M; Zajicek, B | 1 |
Bech, S; Ehlers, L; Eiberg, H; Gjedde, A; Hasholt, L; Hjermind, LE; Lundorf, E; Nielsen, JE; Nørremølle, A; Petersen, T | 1 |
Akanuma, K; Ishii, H; Meguro, K; Meguro, M; Yamaguchi, S | 1 |
Apostolova, LG; Cummings, JL; Dinov, ID; Green, AE; Phelps, ME; Rogers, SA; Silverman, DH; Siu, E; Small, GW; Steiner, CA; Thompson, PM; Toga, AW; Zoumalan, C | 1 |
Amiel, SA | 1 |
Brugnolo, A; Caroli, A; Dessi, B; Frisoni, G; Morbelli, S; Nobili, F; Piccardo, A; Piccini, A; Rodriguez, G; Villavecchia, G | 1 |
De Tiège, X; Paquier, PF; Van Bogaert, P; Verheulpen, D | 1 |
Fujishiro, H; Iseki, E; Kawano, M; Miki, S; Murayama, N; Sato, K; Suzuki, M; Yamamoto, R | 1 |
Buchsbaum, MS; Chu, K; Hazlett, EA; Mitsis, EM; Newmark, RE; Zhang, J | 1 |
Alessandro, S; Brusa, L; Ceravolo, R; Costa, A; Galati, S; Iani, C; Marzetti, F; Peppe, A; Pierantozzi, M; Placidi, F; Romigi, A | 1 |
Haberkorn, U; Henze, M; Hunt, A; Schönknecht, OD; Schröder, J; Toro, P | 1 |
Foster, NL; Jagust, WJ; Koeppe, RA; Landau, SM; Mathis, CA; Petersen, RC; Price, JC; Reiman, EM; Shaw, LM; Trojanowski, JQ; Weiner, MW | 1 |
Brugnolo, A; Dessi, B; Larsson, SA; Mazzei, D; Morbelli, S; Nobili, F; Pagani, M; Piccini, A; Rodriguez, G; Salmaso, D; Villavecchia, G | 1 |
Arai, H; Furukawa, K; Furumoto, S; Iwata, R; Kudo, Y; Okamura, N; Tashiro, M; Waragai, M; Yanai, K | 1 |
Chiti, A; Clerici, F; Del Sole, A; Lecchi, M; Lucignani, G; Maggiore, L; Mariani, C; Mosconi, L; Pomati, S | 1 |
Campa, OM; Harwood, DG; Mandelkern, MA; Melrose, RJ; Sultzer, DL; Walston, A; Woo, BK | 1 |
Boecker, H; Ceballos-Baumann, AO; Drzezga, A; Feurer, R; Förstl, H; Häussermann, P; Kurz, A; Perneczky, R; Valet, M | 1 |
Dhawan, V; Eidelberg, D; Poston, KL; Tang, CC | 1 |
Abbamondi, N; Anfossi, M; Bernardi, L; Bruni, AC; Bugiani, O; Clodomiro, A; Colao, R; Curcio, SA; Di Lorenzo, R; Foncin, JF; Forloni, G; Frangipane, F; Gallo, M; Geracitano, S; Giaccone, G; Leotta, A; Lio, SG; Maletta, R; Milan, G; Mirabelli, M; Muraca, MG; Nee, L; Pappatà, S; Pinessi, L; Postiglione, A; Puccio, G; Rainero, I; Rogaeva, E; Rubino, E; Smirne, N; Sorbi, S; Spillantini, MG; St George Hyslop, P; Terni, B; Tomaino, C | 1 |
Hoffmann, S; Jurkat-Rott, K; Kassubek, J; Lehmann-Horn, F; Lerche, H; Mottaghy, FM; Reske, SN; Roebling, R; Rosenbohm, A; Steinbach, P; Walter, H; Weber, YG; Wolf, M | 1 |
Boeve, BF; Frank, AR; Jack, CR; Kantarci, K; Kemp, BJ; Knopman, DS; Lowe, VJ; Petersen, RC; Senjem, ML; Shiung, MM; Weigand, SD; Wiste, HJ | 1 |
Cheong, HK; Chin, J; Han, SH; Kim, SH; Lee, BH; Na, DL; Seo, SW; Yoon, DS | 1 |
Albin, RL; Burke, JF; Frey, KA; Gilman, S; Giordani, B; Kilbourn, MR; Koeppe, RA | 1 |
Cuasay, K; Devanand, DP; Dileep Kumar, JS; Gunn, RN; Lai, R; Libri, V; Liu, X; Mann, JJ; Mikhno, A; Parsey, RV; Pelton, GH; Pradhaban, G; Upton, N; van Heertum, R | 1 |
Carlis, JV; Dysken, MW; Fink, H; Kuskowski, MA; Lee, JT; Lewis, SM; McCarten, JR; McPherson, S; Munch, KR; Pardo, JV; Rottunda, S; Shah, HH; Sheikh, SA; Surerus, C | 1 |
Bertram, L; Craig, DW; Farrer, LA; Foroud, TM; Green, RC; Huentelman, MJ; Jack, CR; Kim, S; Moore, JH; Nho, K; Potkin, SG; Risacher, SL; Saykin, AJ; Shen, L; Stein, JL; Swaminathan, S; Thompson, PM; Weiner, MW | 1 |
Barthel, H; Becker, G; Frisch, S; Heiner, S; Marschhauser, A; Raczka, KA; Sabri, O; Scheid, R; Schroeter, ML; Seese, A | 1 |
Brusa, L; Ceravolo, R; Galati, S; Pierantozzi, M; Stanzione, P; Stefani, A | 1 |
Chetelat, G; Lippa, CF | 1 |
Aisen, PS; Foster, NL; Harvey, D; Jack, CR; Jagust, WJ; Landau, SM; Madison, CM; Petersen, RC; Reiman, EM; Shaw, LM; Trojanowski, JQ; Weiner, MW | 1 |
Barkhof, F; Blankenstein, MA; Bouwman, FH; Klein, M; Kok, A; Scheltens, P; Sluimer, JD; van der Flier, WM; Verwey, NA | 1 |
Jeong, Y; Lee, MS; Lyoo, CH; Rinne, JO; Ryu, YH | 1 |
Andersen, A; Bastin, C; Bormans, G; Brooks, DJ; Buckley, C; Farrar, G; Garraux, G; Hasselbalch, S; Ivanoiu, A; Korner, A; Law, I; Minthon, L; Nelissen, N; Owenius, R; Salmon, E; Thurfjell, L; Triau, E; Van Laere, K; Vandenberghe, R | 1 |
Arai, H; Fujishiro, H; Iseki, E; Murayama, N; Nagashima, K; Ota, K; Sato, K; Suzuki, M; Yamamoto, R | 1 |
Bartenstein, P; Fellgiebel, A; Hiemke, C; Lotz, J; Müller, MJ; Scheurich, A; Siessmeier, T; Yakushev, I | 1 |
Barbieri, P; Brugnolo, A; Dessi, B; Girtler, N; Mazzei, D; Morbelli, S; Nobili, F; Pagani, M; Rodriguez, G; Sambuceti, G | 1 |
Chaly, T; Dhawan, V; Diaconescu, AO; Eidelberg, D; Hermann, C; Kramer, E; Ma, Y; McIntosh, AR; Smith, GS | 1 |
Herholz, K | 1 |
Chugani, HT; Kumar, A | 1 |
Archambaud, F; Bouilleret, V; Caviness, V; Chiron, C; Dulac, O; Hertz-Pannier, L; Jambaque, I; Mazzuca, M; Rodrigo, S | 1 |
Chaves, R; Górriz, JM; Illán, IA; López, M; Padilla, P; Puntonet, CG; Ramírez, J; Salas-Gonzalez, D; Segovia, F | 1 |
Äikiä, M; Alafuzoff, I; Ikonen, A; Immonen, A; Jutila, L; Kälviäinen, R; Kuikka, J; Lamusuo, S; Mervaala, E; Muraja-Murro, A; Vanninen, E; Vanninen, R; Vapalahti, M | 1 |
Bearden, CE; Brooks, JO; Hoblyn, JC; Ketter, TA; Woodard, SA | 1 |
Becker, G; Guenther, T; Hegerl, U; Hesse, S; Luthardt, J; Meyer, PM; Olbrich, S; Sabri, O; Sander, C; Schönknecht, P | 1 |
Almkvist, O; Bogdanovic, N; Långström, B; Nordberg, A; Schöll, M; Viitanen, M; Wall, A | 1 |
Mancuso, M; Orsucci, D; Siciliano, G; Volterrani, D | 1 |
Becker, JA; Drzezga, A; Greve, D; Johnson, KA; Putcha, D; Schultz, AP; Sepulcre, J; Sperling, RA; Sreenivasan, A; Sullivan, C; Talukdar, T; Van Dijk, KR | 1 |
Bartenstein, P; Buchholz, HG; Buerger, K; Buschert, VC; Drzezga, A; Förster, S; Friese, U; Hampel, H; la Fougere, C; Rominger, A; Teipel, SJ; Zach, C | 1 |
Allain, P; Bachoud-Levi, AC; Bonneau, D; Chauviré, V; Dubas, F; Fasotti, L; Gaura, V; Le Gall, D; Prundean, A; Remy, P; Sherer-Gagou, C; Verny, C | 1 |
Aisen, PS; Hubbard, AE; Jagust, WJ; Lo, RY; Petersen, RC; Shaw, LM; Trojanowski, JQ; Weiner, MW | 1 |
Guenther, T; Haberkorn, U; Henze, M; Hunt, A; Schönknecht, OD; Schröder, J; Toro, P | 1 |
Arnaldi, D; Brugnolo, A; Campus, C; Ferrara, M; Mazzei, D; Mehrdad, N; Morbelli, S; Nobili, F; Rodriguez, G; Sambuceti, G | 1 |
Dunn, G; Haense, C; Herholz, K; Westwood, S | 1 |
Behen, ME; Chugani, HT; Guy, W; Halverson, S; Janisse, J; Juhász, C; Rothermel, R; Wolfe-Christensen, C | 1 |
Archetti, S; Arnaldi, D; di Lorenzo, D; Ferrara, M; Morbelli, S; Nobili, F; Piccini, A; Picco, A; Serrati, C | 1 |
Aarsland, D; Amboni, M; Barone, P; Bronnick, K; Brunetti, A; Caprio, MG; De Michele, G; Erro, R; Longo, K; Pappatà, S; Pellecchia, MT; Salvatore, M; Santangelo, G; Vicidomini, C; Vitale, C | 1 |
Diehl-Schmid, J; Drzezga, A; Kurz, A; Levine, B; Perneczky, R; Spreng, RN | 1 |
Buchholz, HG; Fellgiebel, A; Hampel, H; Lang, U; Muller, MJ; Rossmann, H; Schreckenberger, M; Yakushev, I | 1 |
Barthel, H; Becker, G; Frisch, S; Mueller, K; Sabri, O; Schroeter, ML; Seese, A; Villringer, A; Vogt, B | 1 |
Brera, B; Carro, E; Cuadrado, A; de Ceballos, ML; Delgado, M; García-García, L; Innamorato, NG; Martín-Moreno, AM; Pozo, MA; Spuch, C | 1 |
Beyne-Rauzy, O; Brechemier, D; Dugert, E; Hitzel, A; Julian, A; Le Guellec, S; Wagner, T | 1 |
Beason-Held, LL; Clark, VH; Davatzikos, C; Doshi, J; Ferrucci, L; Kraut, MA; Resnick, SM; Wong, DF; Zhou, Y | 1 |
Brugnolo, A; Caroli, A; Didic, M; Drzezga, A; Frisoni, GB; Guedj, E; Morbelli, S; Nobili, F; Ossenkoppele, R; Pagani, M; Perneczky, R; Salmon, E; Sambuceti, G; van Berckel, BN | 1 |
Aisen, PS; Bernstein, MA; Boeve, BF; Gunter, JL; Jack, CR; Kantarci, K; Knopman, DS; Lesnick, TG; Lowe, V; Petersen, RC; Senjem, ML; Shaw, LM; Trojanowski, JQ; Vemuri, P; Weigand, SD; Weiner, MW; Wiste, HJ | 1 |
Boeve, BF; Gunter, JL; Ivnik, RJ; Jack, CR; Kantarci, K; Knopman, DS; Lowe, V; Petersen, RC; Roberts, RO; Rocca, WA; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
Cummings, M; de Leon, MJ; Glodzik, L; Goldsmith, SJ; Li, Y; McHugh, P; Mosconi, L; Murray, J; Någren, K; Pirraglia, E; Rinne, JO; Scheinin, N; Tsui, WH; Vallabhajosula, S; Viljanen, T; Williams, S | 1 |
Ahnert-Hilger, G; Buchert, R; Dalmau, J; Gomez, A; Harms, L; Höltje, M; Klingbeil, C; Kohler, S; Kopp, U; Maier, N; Probst, C; Prüss, H; Schmitz, D; Schwab, JM; Stoecker, W; Terborg, C; Wandinger, KP | 1 |
Boeve, BF; Gunter, JL; Ivnik, RJ; Jack, CR; Kantarci, K; Knopman, DS; Lowe, V; Petersen, RC; Roberts, RO; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
Eidelberg, D; Feigin, A; Niethammer, M | 1 |
Adriaanse, SF; Barkhof, F; Boellaard, R; Kloet, RW; Lammertsma, AA; Ossenkoppele, R; Scheltens, P; Tolboom, N; van Assema, DM; van Berckel, BN; van der Flier, WM; Windhorst, AD; Zwan, MD | 1 |
Bernardi, S; De Nardis, L; Fiorelli, M; Francia, A; Macci, E | 1 |
Deadwyler, SA; Hampson, RE; Opris, I; Porrino, LJ | 1 |
Tobe, E | 1 |
Jimenez, E; Kaiser, NC; Liu, C; Melrose, RJ; Mendez, MF; Monserratt, L; Su, M; Sultzer, DL | 1 |
Aisen, PS; Jagust, WJ; Joshi, AD; Koeppe, RA; Landau, SM; Mintun, MA; Petersen, RC; Weiner, MW | 1 |
Bai, YM; Hsieh, JC; Lan, CC; Li, CT; Lin, WC; Su, TP; Wang, SJ; Yang, BH | 1 |
Ardito, RB; Baudino, B; Bisi, G; Caroppo, P; Castellano, G; Castelli, L; Cauda, F; Cauda, S; D'agata, F; Geda, E; Geminiani, G; Manfredi, M; Mortara, P; Orsi, L; Pinessi, L; Sacco, K; Torta, R | 1 |
Crane, PK; DeCarli, C; Glymour, MM; Habeck, C; Kim, S; Lee, GJ; Mormino, E; Mukherjee, S; Nho, K; Risacher, S; Saykin, AJ | 1 |
Essig, M; Giesel, F; Guenther, T; Haberkorn, U; Henze, R; Küntzelmann, A; Schönknecht, P; Schröder, J; Schroeter, ML | 1 |
Calhoun, VD; Choudhury, KR; Coleman, RE; Doraiswamy, PM; Petrella, JR; Shaffer, JL; Sheldon, FC | 1 |
Caroli, A; Chen, K; Frisoni, GB; Herholz, K; Jagust, WJ; Prestia, A; Reiman, E | 1 |
Arai, H; Higuchi, S; Iwatsubo, T; Maruyama, M; Matsui, T; Matsushita, S; Ohmori, T; Okamura, N; Takasugi, K | 1 |
Brown, CV; Chen, ST; Cummings, JL; Mahler, ME; Mandelkern, MA; Mendez, MF; Sultzer, DL | 1 |
Chen, SH; Fastenau, PS; Hutchins, GD; Kareken, DA; Trexler, LE | 1 |
Cho, MJ; Kim, JJ; Kim, MS; Kwon, JS; Lee, DS; Lee, DW; Lee, JS; Lee, MC; Lyoo, IK | 1 |
Drzezga, A; Kurz, A; Lautenschlager, N; Minoshima, S; Riemenschneider, M; Schwaiger, M; Siebner, H; Willoch, F | 1 |
Alavi, A; Clark, C; Cotter, A; Newberg, A; Udeshi, M | 1 |
Baron, JC; Berkouk, K; Chetelat, G; de la Sayette, V; Desgranges, B; Dupuy, B; Eustache, F; Hannequin, D; Lalevée, C; Landeau, B; Le Doze, F; Viader, F | 1 |
Bak, TH; Barker, RA; Ho, AK; Manly, T; Nestor, PJ; Robbins, TW; Rosser, AE; Sahakian, BJ | 1 |
Fryer, TD; Hodges, JR; Nestor, PJ; Smielewski, P | 1 |
Ebner, A; Jokeit, H; Nickel, J; Seitz, RJ; Witte, OW; Wunderlich, G | 1 |
Chang, L; Fowler, JS; Hitzemann, R; Logan, J; Ma, Y; Miller, E; Sedler, M; Volkow, ND; Wang, GJ; Zhu, W | 1 |
Benke, T; Delazer, M; Donnemiller, E; Karner, E; Marksteiner, J; Seppi, K | 1 |
Bartenstein, P; Fellgiebel, A; Müller, MJ; Scheurich, A; Schmidt, LG; Siessmeier, T; Winterer, G | 1 |
Baron, JC; Borroni, B; Bracco, L; De Cristofaro, MT; Franceschi, M; Herholz, K; Holthoff, V; Mosconi, L; Nacmias, B; Padovani, A; Perani, D; Pupi, A; Salmon, E; Sorbi, S | 1 |
Alia-Klein, N; Fowler, JS; Goldstein, RZ; Gur, RC; Hitzemann, R; Leskovjan, AC; Volkow, ND; Wang, GJ | 1 |
Mosconi, L | 1 |
Baron, JC; Chételat, G; De La Sayette, V; Desgranges, B; Dupuy, B; Eustache, F; Hannequin, D; Mézenge, F; Pélerin, A; Viader, F | 1 |
Iwama, T; Miwa, K; Nakayama, N; Okumura, A; Shinoda, J; Yasokawa, Y | 1 |
Berman, SM; Brody, AL; Hassid, BD; Ling, W; London, ED; Mandelkern, MA; Monterosso, J; Simon, SL; Voytek, B | 1 |
Döbert, N; Frölich, L; Grünwald, F; Hamscho, N; Menzel, C; Pantel, J | 1 |
Boppana, M; Convit, A; de Leon, MJ; De Santi, S; Li, J; Li, Y; Mosconi, L; Rusinek, H; Tsui, WH | 1 |
Herholz, K; Irle, E; Kracht, L; Lange, C; Sachsse, U | 1 |
Alexopoulus, P; Drzezga, A; Grimmer, T; Kurz, A; Lautenschlager, N; Minoshima, S; Riemenschneider, M; Schwaiger, M; Siebner, H | 1 |
Beuthien-Baumann, B; Collette, F; Delbeuck, X; Garraux, G; Herholz, K; Holthoff, V; Kalbe, E; Lespagnard, S; Marique, P; Pelati, O; Perani, D; Salmon, E | 1 |
Feil, D; Freedman, E; Harwood, DG; Mandelkern, MA; Monserratt, L; Sultzer, DL | 1 |
Anchisi, D; Beuthien-Beumann, B; Borroni, B; Cappa, S; Fazio, F; Franceschi, M; Herholz, K; Holthoff, V; Kalbe, E; Kerrouche, N; Lenz, O; Ludecke, S; Marcone, A; Mielke, R; Ortelli, P; Padovani, A; Pelati, O; Perani, D; Pupi, A; Salmon, E; Scarpini, E; Sorbi, S; Weisenbach, S | 1 |
Boppana, M; de Leon, MJ; De Santi, S; Li, J; Li, Y; Mosconi, L; Pupi, A; Tsui, WH; Zhan, J | 1 |
Beuthien-Baumann, B; Collette, F; Degueldre, C; Herholz, K; Holthoff, V; Lemaire, C; Perani, D; Peters, F; Pupi, A; Salmon, E; Sorbi, S | 1 |
Iwama, T; Nakashima, T; Nakayama, N; Okumura, A; Shinoda, J | 1 |
Bookheimer, SY; Ercoli, L; Huang, SC; Miller, K; Phelps, ME; Siddarth, P; Small, G; Wright, BC | 1 |
Alexopoulos, P; Domes, G; Grimmer, T; Kurz, A; Perneczky, R | 1 |
Almkvist, O; Blomquist, G; Engler, H; Forsberg, A; Långström, B; Larsson, E; Nordberg, A; Ringheim, A; Savitcheva, I; Wall, A | 1 |
Fukuyama, H; Hanakawa, T; Hashikawa, K; Ikeda, A; Ishizu, K; Nagamine, T; Sawamoto, N; Takaya, S | 1 |
Filippini, M; Metz-Lutz, MN | 1 |
Carbon, M; Eidelberg, D; Huang, C; Mattis, P; Perrine, K; Tang, C | 1 |
Barrio, JR; Bookheimer, SY; Burggren, AC; Cole, GM; Ercoli, LM; Huang, SC; Kepe, V; Lavretsky, H; Miller, KJ; Phelps, ME; Satyamurthy, N; Siddarth, P; Small, GW; Thompson, PM; Vinters, HV | 1 |
Diehl-Schmid, J; Drzezga, A; Kurz, A; Perneczky, R; Pohl, C | 1 |
Boppana, M; de Leon, MJ; De Santi, S; Laska, E; Li, J; Li, Y; Mosconi, L; Rusinek, H; Tsui, WH | 1 |
Beuthien-Baumann, B; Donix, M; Herholz, K; Herting, B; Holthoff, VA; Lampe, JB; Pöttrich, K; Reichmann, H; Triemer, A; von Kummer, R | 1 |
Carlis, JV; Dysken, MW; Kuskowski, MA; Lee, JT; Lewis, SM; Munch, KR; Pardo, JV; Shah, H; Sheikh, SA; Surerus-Johnson, C | 1 |
Bessi, V; Bracco, L; Mosconi, L; Piccini, C; Pupi, A; Sorbi, S | 1 |
Diehl-Schmid, J; Drzezga, A; Förstl, H; Kurz, A; Perneczky, R | 1 |
Almkvist, O; Blomquist, G; Engler, H; Forsberg, A; Hagman, G; Långström, B; Nordberg, A; Ringheim, A; Wall, A | 1 |
Borroni, B; Di Luca, M; Padovani, A; Premi, E | 1 |
Haberkorn, U; Henze, M; Hunt, A; Schönknecht, P; Schröder, J; Seidl, U | 1 |
Bartenstein, P; Fellgiebel, A; Müller, MJ; Scheurich, A | 1 |
Drzezga, A; Grimmer, T; Hartmann, J; Kurz, A; Perneczky, R | 1 |
Dupont, P; Fannes, K; Palmini, A; Porke, K; Van Laere, K; Van Paesschen, W; Vandenberghe, R | 1 |
Aronowitz, J; Bloom, R; Brand, J; Brickman, AM; Buchsbaum, MS; Goldstein, KE; Hazlett, EA; Haznedar, MM; Heath, D; Newmark, RE; Starson, M | 1 |
Iwama, T; Kato, T; Nakayama, N; Okumura, A; Shinoda, J; Yasokawa, Y | 1 |
Decarli, C; Ellis, W; Jagust, W; Mungas, D; Reed, B | 1 |
Mariani, E; Mecocci, P; Monastero, R | 1 |
Ghetti, B; Grafman, J; Huey, ED; Murrell, JR; Pietrini, P; Spina, S; Wassermann, EM | 1 |
Kaprio, J; Karrasch, M; Koskenvuo, M; Räihä, I; Rinne, JO; Viljanen, T; Virta, JJ | 1 |
Deadwyler, SA; Hampson, RE; Porrino, L; Siegel, JM | 1 |
Jonker, C; Mulder, JL; Pijnenburg, YA; Scheltens, P; Stevens, M; Uitdehaag, BM; van Swieten, JC | 1 |
Jeong, Y; Lee, JH; Lee, MS; Lee, SY; Lyoo, CH; Rinne, JO; Ryu, YH; Song, TJ | 1 |
Donadieu, J; Hoang-Xuan, K; Idbaih, A; Martin-Duverneuil, N; Remy, P; Ribeiro, MJ; Samson, Y; Thomas, C | 1 |
Boecker, H; Drzezga, A; Förstl, H; Häussermann, P; Kurz, A; Perneczky, R; Wagenpfeil, S | 1 |
Beuthien-Baumann, B; Caselli, R; Clerici, F; de Leon, MJ; Diehl-Schmid, J; Drzezga, A; Herholz, K; Holthoff, V; Kalbe, E; Kurz, A; Lucignani, G; Minoshima, S; Mosconi, L; Perneczky, R; Pupi, A; Reiman, EM; Sorbi, S; Tsui, WH | 1 |
Coslett, HB; Wiener, M | 1 |
Chiti, A; Clerici, F; Del Sole, A; Lecchi, M; Lucignani, G; Maggiore, L; Mariani, C; Mosconi, L | 1 |
Carter, SF; Herholz, K; Jones, M | 1 |
Brooks, R; Chase, TN; Di Chiro, G; Fedio, P; Foster, NL; Mansi, L | 1 |
Brooks, R; Chase, TN; Di Chiro, G; Fedio, P; Foster, NL; Kessler, R; Mansi, L | 1 |
Mayberg, HS | 1 |
Cohen, R; King, AC; Matthew, E; Nordahl, T; Schut, L | 1 |
Hijdra, A; Scheltens, P; van Royen, EA; Weinstein, HC | 1 |
Alberoni, M; Fazio, F; Paulesu, E; Perani, D; Vallar, G | 1 |
Dive, D; Franck, G; Hirsch, E; Maquet, P; Marescaux, C; Metz-Lutz, MN; Motte, J | 1 |
Bonstelle, CT; Chen, K; Kaplan, AM; Lawson, MA; Reiman, EM; Wodrich, DL | 1 |
Ebner, A; Jokeit, H; Markowitsch, HJ; Neumann, N; Seitz, RJ; Witte, OW | 1 |
Doraiswamy, PM; Pitchumoni, S; Steffens, DC; Tabrizi, S | 1 |
de Saint-Martin, A; Hirsch, E; Maquet, P; Marescaux, C; Massa, R; Metz-Lutz, MN; Petiau, C | 1 |
Albers, M; Heiss, WD; Kessler, J; Markowitsch, HJ; Van der Ven, C; Weber-Luxenburger, G | 1 |
Eberling, JL; Ezekiel, F; Jagust, W; Klein, G; O'Neill, J; Reed, B; Schuff, N; Soto, G; Weiner, MW | 1 |
Mountz, JM; San Pedro, EC; Sarangi, S | 1 |
Ayman, M; Carlson, J; Fallon, J; Iacono, R; Keator, D; Lee, A; Lin, SD; Najafi, A; Salmon, E; Wu, JC | 1 |
Balwinski, S; Belenky, G; Dannals, R; Holcomb, H; Mayberg, H; Popp, K; Redmond, D; Rowland, L; Sing, H; Thomas, M; Thorne, D; Wagner, H; Welsh, A | 1 |
Cummings, JL; Dinov, ID; Felix, J; Masterman, DL; Mega, MS; O'Connor, SM; Phelps, ME; Reback, E; Small, GW; Toga, AW | 1 |
Bobinski, M; Caraos, C; Convit, A; de Leon, MJ; DeSanti, S; Fowler, J; Imossi, A; Kandil, E; Lesbre, P; Poirier, J; Reisberg, B; Roche, A; Rusinek, H; Scherer, AJ; Schlyer, D; Tarshish, CY; Thorn, E; Tsui, W; Wolf, OT | 1 |
Emri, M; Halász, P; Mikecz, P; Neuwirth, M; Szakáll, S; Trón, L; Zelei, Z | 1 |
Berg, G; Grady, C; Haxby, JV; Luxenberg, JS; May, C; Moore, A; Rapoport, SI; Robinette, D; White, BJ | 1 |
20 review(s) available for fluorodeoxyglucose f18 and Cognition Disorders
Article | Year |
---|---|
Disorder of Executive Function of the Brain after Head Injury and Mild Traumatic Brain Injury - Neuroimaging and Diagnostic Criteria for Implementation of Administrative Support in Japan.
Topics: Brain Concussion; Chronic Disease; Cognition Disorders; Executive Function; Fluorodeoxyglucose F18; Humans; Japan; Magnetic Resonance Imaging; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Neurodegeneration and the Cerebellum.
Topics: Aged; Cerebellar Diseases; Cerebellum; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Male; Neural Pathways; Neurodegenerative Diseases; Positron-Emission Tomography | 2017 |
The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015.
Topics: Alzheimer Disease; Apolipoprotein E4; Brain; Brain Mapping; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Longitudinal Studies; Positron-Emission Tomography | 2015 |
Cerebrospinal fluid: when is it worthwhile to do a lumbar puncture?
Topics: Alzheimer Disease; Cognition Disorders; Creutzfeldt-Jakob Syndrome; Dementia; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Puncture; tau Proteins; Temporal Lobe | 2008 |
Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis.
Topics: Alzheimer Disease; Cognition Disorders; Disease Progression; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Predictive Value of Tests; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon | 2009 |
Amyloid PET and MRI in Alzheimer's disease and mild cognitive impairment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Brain Mapping; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Thiazoles | 2009 |
Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: focus on sleep and cognitive domains.
Topics: Brain Mapping; Cognition Disorders; Deep Brain Stimulation; Electrodes, Implanted; Executive Function; Fluorodeoxyglucose F18; Humans; Memory, Short-Term; Neuropsychological Tests; Parkinsonian Disorders; Pedunculopontine Tegmental Nucleus; Positron-Emission Tomography; Sleep Wake Disorders; Subthalamic Nucleus | 2010 |
Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Cognition Disorders; Disease Progression; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography | 2010 |
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD).
Topics: Aniline Compounds; Benzothiazoles; Brain; Brain Mapping; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography; Thiazoles; Tomography, Emission-Computed, Single-Photon | 2011 |
Functional neuroimaging in Parkinson's disease.
Topics: Antiparkinson Agents; Brain Diseases, Metabolic; Cognition Disorders; Disease Progression; Dopamine; Dyskinesia, Drug-Induced; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Levodopa; Lewy Bodies; Magnetic Resonance Imaging; Neurotransmitter Agents; Parkinson Disease; Positron-Emission Tomography; Psychomotor Disorders; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2012 |
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
Topics: Alzheimer Disease; Animals; Brain; Cognition Disorders; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Tissue Distribution | 2005 |
Neuropsychological findings in Rolandic epilepsy and Landau-Kleffner syndrome.
Topics: Adolescent; Auditory Cortex; Child; Child, Preschool; Cognition Disorders; Electroencephalography; Epilepsy, Rolandic; Fluorodeoxyglucose F18; Humans; Landau-Kleffner Syndrome; Language Development; Longitudinal Studies; Neuropsychological Tests; Positron-Emission Tomography; Sleep; Verbal Learning | 2006 |
Combined biomarkers for early Alzheimer disease diagnosis.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Proteome; Serum Amyloid A Protein; tau Proteins | 2007 |
Mild cognitive impairment: a systematic review.
Topics: Alzheimer Disease; Apolipoprotein E4; Brain; Cognition Disorders; Dementia, Vascular; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Memory Disorders; Neuropsychological Tests; Radiopharmaceuticals; Risk Factors; Severity of Illness Index | 2007 |
Positron emission tomography imaging in dementia.
Topics: Alzheimer Disease; Blood Glucose; Brain; Cognition Disorders; Dementia; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Neurotransmitter Agents; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Clinical correlates of PET- and SPECT-identified defects in dementia.
Topics: Alzheimer Disease; Brain; Cognition Disorders; Delusions; Dementia; Deoxyglucose; Depressive Disorder; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organotechnetium Compounds; Oximes; Severity of Illness Index; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1994 |
Neuro-imaging in the diagnosis of Alzheimer's disease. II. Positron and single photon emission tomography.
Topics: Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition Disorders; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1993 |
Early recognition of Alzheimer's disease: what is consensual? What is controversial? What is practical?
Topics: Aged; Alzheimer Disease; Brain; Cognition Disorders; Decision Trees; Delirium; Dementia, Vascular; Depressive Disorder; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Incidence; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Memory Disorders; Severity of Illness Index; Tomography, Emission-Computed | 1998 |
[The role of PET scan in the investigation of epileptic functional disorders].
Topics: Brain; Cognition Disorders; Electroencephalography; Epilepsies, Partial; Epilepsy; Epilepsy, Temporal Lobe; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Oxygen Radioisotopes; Sclerosis; Speech Disorders; Tomography, Emission-Computed | 2002 |
Assessment: positron emission tomography. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Topics: Brain Neoplasms; Cognition Disorders; Dementia; Deoxyglucose; Diagnosis, Differential; Evaluation Studies as Topic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Humans; Oxygen Radioisotopes; Preoperative Care; Seizures; Tomography, Emission-Computed | 1991 |
11 trial(s) available for fluorodeoxyglucose f18 and Cognition Disorders
Article | Year |
---|---|
Challenges in Screening and Recruitment for a Neuroimaging Study in Cognitively Impaired Geriatric Inpatients.
Topics: Aged; Aged, 80 and over; Algorithms; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Geriatric Assessment; Humans; Image Processing, Computer-Assisted; Inpatients; Male; Neuroimaging; Neuropsychological Tests; Positron-Emission Tomography; Prospective Studies | 2017 |
Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Apolipoprotein E4; Celecoxib; Cerebral Cortex; Cognition Disorders; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Pyrazoles; Radiopharmaceuticals; Sulfonamides; Treatment Outcome | 2008 |
Surface feature-guided mapping of cerebral metabolic changes in cognitively normal and mildly impaired elderly.
Topics: Aged; Aged, 80 and over; Brain; Brain Mapping; Cognition; Cognition Disorders; Demography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Surface Properties | 2010 |
Effects of age on the glucose metabolic changes in mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Atrophy; Biomarkers; Blood Glucose; Cognition Disorders; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parietal Lobe; Positron-Emission Tomography; Reproducibility of Results; Temporal Lobe | 2010 |
18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Brain; Cognition Disorders; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thiazoles | 2010 |
Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Brain; Cognition Disorders; Cognitive Behavioral Therapy; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients.
Topics: Antineoplastic Agents; Brain; Cognition; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
Topics: Aged; Alzheimer Disease; Brain Mapping; Cerebral Cortex; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Male; Neuropsychological Tests; Prognosis; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tomography, Emission-Computed | 2003 |
A metabolic imaging severity rating scale for the assessment of cognitive impairment.
Topics: Brain; Brain Mapping; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Psychological Tests; Radiopharmaceuticals; Severity of Illness Index; Statistics as Topic; Tomography, Emission-Computed | 2003 |
Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
Topics: Aged; Alzheimer Disease; Apolipoproteins E; Cognition Disorders; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Genetic Testing; Humans; Male; Phenotype; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2005 |
Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cholinesterase Inhibitors; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Trichlorfon | 2001 |
241 other study(ies) available for fluorodeoxyglucose f18 and Cognition Disorders
Article | Year |
---|---|
Structural and metabolic brain correlates of arithmetic word-problem solving in Huntington's disease.
Topics: Brain; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Huntington Disease; Magnetic Resonance Imaging; Problem Solving | 2023 |
Broader phenotypic traits and widespread brain hypometabolism in spinocerebellar ataxia 27.
Topics: Adolescent; Adult; Animals; Attention Deficit Disorder with Hyperactivity; Brain; Chromosome Deletion; Chromosomes, Human, Pair 13; Cognition Disorders; Fibroblast Growth Factors; Fluorodeoxyglucose F18; Genotype; Humans; Immunohistochemistry; Integrin beta1; Magnetic Resonance Imaging; Mice, Knockout; Neuroimaging; Neuropsychological Tests; Pedigree; Phenotype; Positron-Emission Tomography; Prefrontal Cortex; Psychotic Disorders; Radiopharmaceuticals; Spinocerebellar Degenerations; Sweden; Vesicular Inhibitory Amino Acid Transport Proteins; Young Adult | 2020 |
COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings.
Topics: Aged; Brain Diseases; Cerebellar Diseases; Cognition Disorders; COVID-19; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Immunotherapy; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Myoclonus; Neuropsychological Tests; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Status Epilepticus; Treatment Outcome | 2020 |
123I-Ioflupane SPECT and 18F-FDG PET Combined Use in the Characterization of Movement and Cognitive Associated Disorders in Neurodegenerative Diseases.
Topics: Alzheimer Disease; Brain; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Movement Disorders; Neurodegenerative Diseases; Nortropanes; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2021 |
Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prodromal Symptoms; Time Factors | 2017 |
Reduced glucose metabolism in neocortical network nodes remote from hypothalamic hamartomas reflects cognitive impairment.
Topics: Adolescent; Adult; Blood Glucose; Child; Cognition Disorders; Dominance, Cerebral; Electroencephalography; Female; Fluorodeoxyglucose F18; Hamartoma; Humans; Hypothalamic Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Neocortex; Nerve Net; Neuropsychological Tests; Positron-Emission Tomography; Ranvier's Nodes; Retrospective Studies; Signal Processing, Computer-Assisted; Young Adult | 2017 |
Functional Disintegration of the Default Mode Network in Prodromal Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Analysis of Variance; Cognition Disorders; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Models, Neurological; Neural Pathways; Neuropsychological Tests; Oxygen; Positron-Emission Tomography; Prodromal Symptoms; Psychiatric Status Rating Scales; Surveys and Questionnaires | 2017 |
Long-Standing Isolated Autoimmune Hypothalamitis Diagnosed with Endoscopic Transventricular Biopsy.
Topics: Aged; Autoimmune Diseases; Biopsy; Cognition Disorders; Diabetes Insipidus; Endoscopy; Female; Fluorodeoxyglucose F18; Humans; Hypopituitarism; Hypothalamic Diseases; Ki-67 Antigen; Magnetic Resonance Imaging; Positron-Emission Tomography | 2017 |
Cortical Metabolic and Cognitive Correlates of Disorientation in Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Cognition Disorders; Confusion; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Tomography Scanners, X-Ray Computed | 2017 |
PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).
Topics: Adult; Amyloid; Apolipoproteins E; Cerebellum; Cognition Disorders; Cohort Studies; Down Syndrome; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; tau Proteins | 2017 |
Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson's disease.
Topics: Adult; Aged; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Neuropsychological Tests; Parietal Lobe; Parkinson Disease; Positron-Emission Tomography | 2018 |
Reversible sub-acute cognitive deterioration in cerebral amyloid angiopathy: A case report.
Topics: Aged; Cerebral Amyloid Angiopathy; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Social Behavior; White Matter | 2018 |
Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Aniline Compounds; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Models, Neurological; Neural Pathways; Positron-Emission Tomography; Thiazoles | 2018 |
Novel Features and Abnormal Pattern of Cerebral Glucose Metabolism in Spinocerebellar Ataxia 19.
Topics: Aged; Cerebral Cortex; Cognition Disorders; Family Health; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Positron-Emission Tomography; Shal Potassium Channels; Spinocerebellar Degenerations; Young Adult | 2018 |
Neurocognition, sleep, and PET findings in type 2 vs type 1 narcolepsy.
Topics: Adolescent; Adult; Brain; Case-Control Studies; Child; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Narcolepsy; Neuropsychological Tests; Polysomnography; Positron-Emission Tomography; Severity of Illness Index; Sleep Wake Disorders; Young Adult | 2018 |
Structural and metabolic brain correlates of apathy in Huntington's disease.
Topics: Aged; Apathy; Atrophy; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Huntington Disease; Imaging, Three-Dimensional; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Tomography Scanners, X-Ray Computed | 2018 |
Can 11C-PiB-PET Relative Delivery R1 or 11C-PiB-PET Perfusion Replace 18F-FDG-PET in the Assessment of Brain Neurodegeneration?
Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Brain; Carbon Radioisotopes; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Tomography Scanners, X-Ray Computed | 2018 |
Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.
Topics: Adolescent; Adult; Brain; Child; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Machine Learning; Male; Neurofibromatosis 1; Neuropsychological Tests; Positron Emission Tomography Computed Tomography; Principal Component Analysis; Young Adult | 2018 |
Crossed Cerebellar Diaschisis in Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Cerebellum; Cognition Disorders; Depression; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Thiazoles | 2018 |
Global and regional brain hypometabolism on FDG-PET in treated HIV-infected individuals.
Topics: Anti-Retroviral Agents; Brain; Case-Control Studies; Cholesterol; Cognition Disorders; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2018 |
Frontotemporal Dementia Misdiagnosed for Post-Treatment Lyme Disease Syndrome or vice versa? A Treviso Dementia (TREDEM) Registry Case Report.
Topics: Cognition Disorders; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Iofetamine; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Post-Lyme Disease Syndrome; Tomography, Emission-Computed, Single-Photon | 2018 |
The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly.
Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Aniline Compounds; Apolipoproteins E; Brain; Cognition Disorders; Cohort Studies; Female; Fluorodeoxyglucose F18; Genotype; Geriatric Assessment; Humans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Regression Analysis; Thiazoles | 2013 |
Semi-supervised multimodal relevance vector regression improves cognitive performance estimation from imaging and biological biomarkers.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Artificial Intelligence; Biomarkers; Brain Mapping; Cognition Disorders; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; National Institutes of Health (U.S.); Neuropsychological Tests; Positron-Emission Tomography; Regression Analysis; Reproducibility of Results; United States | 2013 |
Evoked potentials and neuropsychological tests validate Positron Emission Topography (PET) brain metabolism in cognitively impaired patients.
Topics: Adult; Aged; Brain; Cognition Disorders; Cognitive Dysfunction; Event-Related Potentials, P300; Fluorodeoxyglucose F18; Humans; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid; Analysis of Variance; Aniline Compounds; Biomarkers; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radioisotopes; Reproducibility of Results; Thiazoles | 2013 |
Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease.
Topics: Acetylcholine; Acetylcholinesterase; Aged; Alzheimer Disease; Aniline Compounds; Astrocytes; Butyrylcholinesterase; Calcium-Binding Proteins; Cells, Cultured; Cognition Disorders; Complement System Proteins; Cytokines; DNA-Binding Proteins; Female; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Humans; Male; Mental Status Schedule; Microfilament Proteins; Neuropsychological Tests; Polymorphism, Single Nucleotide; Radionuclide Imaging; S100 Calcium Binding Protein beta Subunit; Thiazoles | 2013 |
Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia.
Topics: Aged; Amyloid beta-Peptides; Aniline Compounds; Aphasia, Primary Progressive; Atrophy; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Intracranial Hemorrhages; Male; Middle Aged; Nerve Fibers, Myelinated; Neuroimaging; Neuropsychological Tests; Occipital Lobe; Radionuclide Imaging; Thiazoles | 2013 |
Visual hallucinations and cognitive impairment in Parkinson's disease.
Topics: Aged; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Hallucinations; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index | 2013 |
Clinical and imaging characterization of progressive spastic dysarthria.
Topics: Aged; Aged, 80 and over; Brain; Cognition Disorders; Disease Progression; Dysarthria; Female; Fluorodeoxyglucose F18; Humans; Intellectual Disability; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2014 |
Resolution of neuropsychological and FDG-PET abnormalities in a patient with neuropsychiatric systemic lupus erythematosus.
Topics: Brain; Cerebral Cortex; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Middle Aged; Mycophenolic Acid; Neuropsychological Tests; Positron-Emission Tomography; Prednisone; Remission Induction; Tomography, X-Ray Computed | 2013 |
Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Incidence; Magnetic Resonance Imaging; Male; Neurodegenerative Diseases; Oxygen; Positron-Emission Tomography | 2013 |
Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Cognition Disorders; Cohort Studies; Community-Based Participatory Research; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Nerve Fibers, Myelinated; Neurodegenerative Diseases; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Thiazoles | 2013 |
Neural correlates of cognitive dysfunction in Lewy body diseases and tauopathies: combined assessment with FDG-PET and the CERAD test battery.
Topics: Aged; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Learning; Lewy Body Disease; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Semantics; Tauopathies | 2013 |
Amyloid imaging with (11)C-PIB PET/CT and glucose metabolism with (18)F-FDG PET/CT in a study on cognitive impairment in the clinical setting.
Topics: Adult; Aged; Aged, 80 and over; Amyloid; Aniline Compounds; Benzothiazoles; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multimodal Imaging; Neuroimaging; Positron-Emission Tomography; Thiazoles; Tomography, X-Ray Computed | 2014 |
Correlation between interictal cerebral glucose hypometabolism and IQ in children with epilepsy.
Topics: Adolescent; Analysis of Variance; Cerebral Cortex; Child; Cognition Disorders; Epilepsy; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Intelligence; Intelligence Tests; Male; Positron-Emission Tomography; Statistics as Topic | 2014 |
Practical utility of amyloid and FDG-PET in an academic dementia center.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Severity of Illness Index; Thiazoles | 2014 |
Dynamic metabolic changes after permanent cerebral ischemia in rats with/without post-stroke exercise: a positron emission tomography (PET) study.
Topics: Animals; Brain; Brain Ischemia; Cognition Disorders; Corpus Striatum; Disease Models, Animal; Fluorodeoxyglucose F18; Functional Laterality; Longitudinal Studies; Male; Motor Cortex; Neuropsychological Tests; Physical Conditioning, Animal; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; Rats; Rats, Sprague-Dawley; Stroke; Time Factors; Treatment Outcome | 2014 |
Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition Disorders; Cysteine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Observer Variation; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2014 |
Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease.
Topics: Adult; Cognition Disorders; Cohort Studies; Corpus Striatum; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Psychomotor Disorders; Statistics, Nonparametric | 2014 |
Is anterior communicating artery syndrome related to fornix lesions?
Topics: Aged; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Fornix, Brain; Humans; Intracranial Aneurysm; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Severity of Illness Index | 2014 |
Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cognition Disorders; Databases, Factual; Disease Progression; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Memory; Mental Status Schedule; Neuropsychological Tests; Positron-Emission Tomography | 2014 |
Cognitive dysfunctions in middle-aged type 2 diabetic patients and neuroimaging correlations: a cross-sectional study.
Topics: Aged; Brain; Cognition Disorders; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Voltage-gated potassium channel (VGKC) antibody-associated encephalopathy presenting as psychosis: a case report.
Topics: Autoantibodies; Brain Diseases; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Potassium Channels, Voltage-Gated; Psychotic Disorders | 2014 |
The Alzheimer's disease-related glucose metabolic brain pattern.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2014 |
Regional brain glucose metabolism and neurocognitive function in adult survivors of childhood cancer treated with cranial radiation.
Topics: Adult; Brain; Cognition; Cognition Disorders; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Multimodal Imaging; Neuropsychological Tests; Positron-Emission Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment.
Topics: Adult; Aged; Alzheimer Disease; Biomarkers; Cerebral Cortex; Cognition Disorders; Cognitive Dysfunction; Depression; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Functional imaging in neurodegenerative disorders: past, present and future.
Topics: Cognition Disorders; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neurodegenerative Diseases; Positron-Emission Tomography | 2014 |
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoprotein E4; Cognition Disorders; Cohort Studies; Ethylene Glycols; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography | 2015 |
Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes.
Topics: Aged; Aged, 80 and over; Amyloid; Aphasia, Primary Progressive; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Statistics, Nonparametric; Tomography, X-Ray Computed | 2015 |
Melancholia Associated With Severe Cognitive Disorders as the Expression of Late-Onset Postpartum Anti-N-Methyl-d-Aspartic Acid Receptor Limbic Encephalitis.
Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Brain; Cognition Disorders; Depressive Disorder; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Postpartum Period | 2015 |
Metabolic Activity of Red Nucleus and Its Correlation with Cerebral Cortex and Cerebellum: A Study Using a High-Resolution Semiconductor PET System.
Topics: Adult; Aged; Brain; Brain Mapping; Cerebellum; Cerebral Cortex; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Red Nucleus; Reproducibility of Results; Retrospective Studies; Semiconductors | 2015 |
Drug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study.
Topics: Aged; Alzheimer Disease; Anticonvulsants; Antidepressive Agents; Attention; Cognition Disorders; Depressive Disorder, Major; Diagnosis, Differential; Drug Therapy, Combination; Essential Tremor; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Humans; Lithium Compounds; Male; Memory Disorders; Memory, Episodic; Mental Recall; Neuropsychological Tests; Positron-Emission Tomography; Primidone; Radiopharmaceuticals; Recurrence; Venlafaxine Hydrochloride | 2015 |
Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Cognition Disorders; Cross-Sectional Studies; Diabetes Mellitus; Female; Fluorodeoxyglucose F18; Glucose; Humans; Ideal Body Weight; Insulin Resistance; Male; Middle Aged; Positron-Emission Tomography; Statistics as Topic | 2015 |
Anti-Ma2 Antibody Encephalitis Manifesting as Cognitive Impairment and Psychosis.
Topics: Antibodies; Antigens, Neoplasm; Brain; Cognition Disorders; Encephalitis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Tissue Proteins; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.
Topics: Acetazolamide; Aged; Brain; Carotid Stenosis; Cerebrovascular Circulation; Cognition Disorders; Cohort Studies; Endarterectomy, Carotid; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2015 |
Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Cognition Disorders; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nervous System Diseases; Positron-Emission Tomography; Retrospective Studies; Statistics, Nonparametric; Tomography, Emission-Computed, Single-Photon | 2015 |
The Possible Link between GABAergic Dysfunction and Cognitive Decline in a Patient with Idiopathic Hypoparathyroidism.
Topics: Aged; Basal Ganglia; Brain; Calcinosis; Cerebellum; Cerebral Cortex; Cognition; Cognition Disorders; Fluorodeoxyglucose F18; gamma-Aminobutyric Acid; Humans; Hypoparathyroidism; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, GABA-B; Thalamus; Tomography, X-Ray Computed | 2015 |
Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson's Disease.
Topics: Brain; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Mental Status Schedule; Parkinson Disease; Positron-Emission Tomography; Temporal Lobe | 2015 |
Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidogenic Proteins; Cerebral Cortex; Cognition Disorders; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Mood Disorders; Neuropsychological Tests; Positron-Emission Tomography | 2016 |
18F-FDG-PET correlates of cognitive impairment in ALS.
Topics: Aged; Amyotrophic Lateral Sclerosis; Cognition Disorders; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2016 |
A case of progressive frontal lobe syndrome in a sporadic form of Cerebral Amyloid Angiopathy: A singular overlap with fronto-temporal dementia?
Topics: Aged; Cerebral Amyloid Angiopathy; Cognition Disorders; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography | 2015 |
Cognitive impairment in ALS patients and validation of the Spanish version of the ALS-CBS test.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychomotor Disorders; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Translating | 2016 |
ST09, a Novel Thioester Derivative of Tacrine, Alleviates Cognitive Deficits and Enhances Glucose Metabolism in Vascular Dementia Rats.
Topics: Acetylcholinesterase; Animals; Apoptosis; Cell Line, Transformed; Cerebral Cortex; Cognition Disorders; Dementia, Vascular; Disease Models, Animal; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Fluorodeoxyglucose F18; Glucose; Hippocampus; In Vitro Techniques; Male; Maze Learning; Niacinamide; Nootropic Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tacrine | 2016 |
The Neural Basis of Postural Instability Gait Disorder Subtype of Parkinson's Disease: A PET and fMRI Study.
Topics: Aged; Cognition Disorders; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Oxygen; Parkinson Disease; Positron-Emission Tomography; Postural Balance; Severity of Illness Index; Tremor | 2016 |
Voxel-based statistical analysis of brain metabolism in patients with growth hormone deficiency after traumatic brain injury.
Topics: Adult; Brain; Brain Injuries, Traumatic; Cognition Disorders; Diffuse Axonal Injury; Female; Fluorodeoxyglucose F18; Glasgow Coma Scale; Glucose; Growth Hormone; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Young Adult | 2016 |
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.
Topics: Aged; Aged, 80 and over; Apolipoprotein E4; Atrophy; Brain; Cholinergic Antagonists; Cognition Disorders; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography; Proportional Hazards Models | 2016 |
Preserved brain metabolic activity at the age of 96 years.
Topics: Aged, 80 and over; Brain; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2016 |
Reversible disconnection syndrome in a case of acute tumefactive demyelinating lesion: a PET study.
Topics: Adult; Brain; Cognition Disorders; Demyelinating Diseases; Electroencephalography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2016 |
Case report of Lewy body disease mimicking Creutzfeldt-Jakob disease in a 44-year-old man.
Topics: 14-3-3 Proteins; Adult; Brain; Cognition Disorders; Creutzfeldt-Jakob Syndrome; Delusions; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Neuroimaging; Parkinsonian Disorders; Positron-Emission Tomography | 2016 |
PET Evidence of the Effect of Donepezil on Cognitive Performance in an Animal Model of Chemobrain.
Topics: Animals; Antineoplastic Agents; Brain; Cognition; Cognition Disorders; Disease Models, Animal; Donepezil; Female; Fluorodeoxyglucose F18; Indans; Maze Learning; Memory; Piperidines; Positron-Emission Tomography; Rats, Sprague-Dawley | 2016 |
Plasma tau in Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Cognition Disorders; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; tau Proteins | 2016 |
Female advantage in verbal memory: Evidence of sex-specific cognitive reserve.
Topics: Acoustic Stimulation; Aged; Aged, 80 and over; Alzheimer Disease; Apolipoproteins E; Cognition Disorders; Cognitive Reserve; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Male; Mental Status Schedule; Neuropsychological Tests; Positron-Emission Tomography; Sex Characteristics; Verbal Learning | 2016 |
Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brain; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinsonian Disorders; Positron-Emission Tomography; Psychiatric Status Rating Scales; Severity of Illness Index | 2016 |
Brain
Topics: Adolescent; Adult; Aged; Brain; Brain Diseases, Metabolic; Chronic Disease; Cognition Disorders; Fasciitis; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Myositis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2017 |
Mediodorsal nucleus and its multiple cognitive functions.
Topics: Aged; Attention; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Mediodorsal Thalamic Nucleus; Memory Disorders; Neural Pathways; Neurons; Neuropsychological Tests; Positron-Emission Tomography; Recognition, Psychology; Smell | 2016 |
In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Brain; Carbolines; Cognition Disorders; Corticomedial Nuclear Complex; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Language Disorders; Male; Neuropsychological Tests; Positron-Emission Tomography; tau Proteins | 2017 |
Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Cerebral Cortex; Cognition Disorders; Cross-Sectional Studies; Dementia; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index | 2017 |
18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Autoradiography; Brain; Carbolines; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Protein Binding; Psychiatric Status Rating Scales; Supranuclear Palsy, Progressive; tau Proteins | 2017 |
Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease.
Topics: Alzheimer Disease; Chi-Square Distribution; Cognition Disorders; Cognitive Reserve; Epilepsy; Female; Fluorodeoxyglucose F18; Frontal Lobe; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Nerve Net; Neuropsychological Tests; Oxygen; Positron-Emission Tomography; Prodromal Symptoms | 2017 |
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cognition Disorders; Diagnosis, Computer-Assisted; Diagnosis, Differential; Disease Progression; Europe; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; tau Proteins; Tomography, Emission-Computed, Single-Photon | 2017 |
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Regression Analysis; Sensitivity and Specificity; Thiazoles | 2008 |
SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging.
Topics: Aged; Aging; Algorithms; Alzheimer Disease; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Radionuclide Imaging; Retrospective Studies | 2009 |
Dose-dependent effects of radiation therapy on cerebral blood flow, metabolism, and neurocognitive dysfunction.
Topics: Adult; Aged; Brain; Brain Neoplasms; Cerebrovascular Circulation; Cognition Disorders; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Conformal; Young Adult | 2009 |
Effect of citalopram in treating hypersexuality in an Alzheimer's disease case.
Topics: Alzheimer Disease; Brain; Citalopram; Cognition Disorders; Disease Progression; Donepezil; Fluorodeoxyglucose F18; Humans; Indans; Male; Memory Disorders; Middle Aged; Mood Disorders; Nootropic Agents; Obsessive-Compulsive Disorder; Piperidines; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome | 2008 |
Multi-modal imaging predicts memory performance in normal aging and cognitive decline.
Topics: Aged; Aged, 80 and over; Aging; Cognition Disorders; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Memory; Memory Disorders; Mental Recall; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis | 2010 |
Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18.
Topics: Adolescent; Aged; Alzheimer Disease; Cerebellum; Cognition Disorders; Female; Fluorodeoxyglucose F18; Frontal Lobe; Gyrus Cinguli; Humans; Male; Motor Cortex; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Somatosensory Cortex; Temporal Lobe | 2008 |
Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cognition Disorders; Educational Status; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Occupations; Positron-Emission Tomography | 2008 |
A novel insertional mutation in the prion protein gene: clinical and bio-molecular findings.
Topics: Adult; Brain; Cloning, Molecular; Cognition Disorders; Dementia; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Models, Genetic; Mutation; Neurodegenerative Diseases; Prion Proteins; Prions; Radiopharmaceuticals; Recombinant Proteins | 2008 |
Rasmussen's encephalitis and Behcet's disease: autoimmune disorders in first degree relatives.
Topics: Adolescent; Anticonvulsants; Basal Ganglia; Behcet Syndrome; Cognition Disorders; Drug Resistance; Dyskinesias; Dystonia; Encephalitis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Paresis; Positron-Emission Tomography; Radiopharmaceuticals; Seizures | 2008 |
Correlation between cognitive deficits and glucose hypometabolism in mild cognitive impairment.
Topics: Aged; Brain; Brain Mapping; Cognition Disorders; Executive Function; Female; Fluorodeoxyglucose F18; Glucose; Humans; Linear Models; Male; Mental Recall; Neuropsychological Tests; Positron-Emission Tomography; Prospective Studies; Visual Perception | 2010 |
Subcortical vascular versus amnestic mild cognitive impairment: comparison of cerebral glucose metabolism.
Topics: Aged; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography | 2009 |
Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Brain; Cognition Disorders; Disease Progression; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Japan; Magnetic Resonance Imaging; Male; Mental Status Schedule; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Psychometrics; Reference Values; Temporal Lobe | 2009 |
FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Brain; Cognition Disorders; Dementia, Vascular; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Lewy Body Disease; Male; Positron-Emission Tomography | 2009 |
Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment.
Topics: Aged; Brain Mapping; Cerebrovascular Circulation; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinsonian Disorders; Positron-Emission Tomography; Severity of Illness Index; Statistics as Topic | 2009 |
A combined neuropsychological and brain imaging study of obstructive sleep apnea.
Topics: Ataxia; Atrophy; Attention; Blood Glucose; Brain; Cerebral Cortex; Cognition Disorders; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Polysomnography; Positron-Emission Tomography; Sleep Apnea, Obstructive | 2009 |
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2009 |
Dose-dependent frontal hypometabolism on FDG-PET in methamphetamine abusers.
Topics: Adult; Amphetamine-Related Disorders; Brain Mapping; Case-Control Studies; Cognition Disorders; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Statistics, Nonparametric | 2009 |
Comparison of 18F-FDG and PiB PET in cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2009 |
Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Brain; Brain Mapping; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2009 |
Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET.
Topics: Aged; Aged, 80 and over; Brain Mapping; Cerebral Cortex; Chi-Square Distribution; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index; Statistics, Nonparametric | 2009 |
Huntington's disease-like and ataxia syndromes: identification of a family with a de novo SCA17/TBP mutation.
Topics: Adult; Ataxia; Cognition Disorders; Electroencephalography; Family Health; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; TATA-Box Binding Protein; Temporal Lobe; Trinucleotide Repeat Expansion | 2010 |
Assessment of mental deterioration with the Cognitive Abilities Screening Instrument (CASI) and glucose hypometabolism in Alzheimer's disease: the Osaki-Tajiri Project.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brain; Brain Mapping; Cognition Disorders; Community-Based Participatory Research; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose Metabolism Disorders; Humans; Male; Mental Disorders; Mental Status Schedule; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Ultrasonography | 2009 |
Hypoglycemia: from the laboratory to the clinic.
Topics: Awareness; Brain; Cognition Disorders; Diabetes Mellitus; Epinephrine; Fluorodeoxyglucose F18; Heart; Homeostasis; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Radionuclide Imaging; Reference Values | 2009 |
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study.
Topics: Aged; Aged, 80 and over; Amnesia; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique | 2010 |
Acquired cognitive dysfunction with focal sleep spiking activity.
Topics: Brain; Cognition Disorders; Comorbidity; Electroencephalography; Epilepsy, Rolandic; Fluorodeoxyglucose F18; Functional Laterality; Humans; Neuropsychological Tests; Perceptual Disorders; Positron-Emission Tomography; Sleep; Sleep, REM | 2009 |
Construction of a (18)F-FDG PET normative database of Japanese healthy elderly subjects and its application to demented and mild cognitive impairment patients.
Topics: Adult; Aged; Aged, 80 and over; Cognition Disorders; Databases, Factual; Dementia; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Memory Disorders; Middle Aged; Positron-Emission Tomography; Psychiatric Status Rating Scales; Radiopharmaceuticals | 2010 |
Statistical parametric mapping and cluster counting analysis of [18F] FDG-PET imaging in traumatic brain injury.
Topics: Adult; Brain; Brain Injuries; Brain Mapping; Cerebral Hemorrhage, Traumatic; Cognition Disorders; Data Interpretation, Statistical; Diffuse Axonal Injury; Energy Metabolism; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Temporal Lobe; Thalamus | 2010 |
Neural correlates of delayed episodic memory in patients with mild cognitive impairment--a FDG PET study.
Topics: Aged; Cognition Disorders; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Memory; Positron-Emission Tomography; Radiopharmaceuticals; Verbal Behavior | 2009 |
Relationships between biomarkers in aging and dementia.
Topics: Aged; Aging; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Peptide Fragments; Positron-Emission Tomography; Psychiatric Status Rating Scales; tau Proteins; Thiazoles | 2009 |
MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings.
Topics: Aged; Aged, 80 and over; Brain Mapping; Cognition Disorders; Dementia; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Functional Laterality; Humans; Image Processing, Computer-Assisted; Male; Memory Disorders; Positron-Emission Tomography; Predictive Value of Tests; Prognosis | 2010 |
Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.
Topics: Aged; Alzheimer Disease; Amyloid; Benzoxazoles; Brain; Brain Mapping; Carbon Radioisotopes; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Plaque, Amyloid; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Thiazoles | 2010 |
Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis.
Topics: Aged; Amnesia; Automation; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Temporal Lobe | 2009 |
Executive deficits and regional brain metabolism in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Cognition Disorders; Executive Function; Female; Fluorodeoxyglucose F18; Geriatric Assessment; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Radiopharmaceuticals | 2010 |
Metabolic alterations associated with impaired clock drawing in Lewy body dementia.
Topics: Aged; Analysis of Variance; Brain; Brain Mapping; Cognition Disorders; Executive Function; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Lewy Body Disease; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Photic Stimulation; Positron-Emission Tomography; Space Perception | 2010 |
Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease.
Topics: Aged; Analysis of Variance; Brain Mapping; Cerebrovascular Circulation; Cognition Disorders; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Longitudinal Studies; Male; Metabolic Networks and Pathways; Middle Aged; Motor Activity; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Statistics as Topic; Time Factors | 2010 |
Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation.
Topics: Adult; Alzheimer Disease; Brain; Cognition Disorders; Family Health; Female; Fluorodeoxyglucose F18; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Global Health; History, 17th Century; History, 21st Century; Humans; International Cooperation; Italy; Leucine; Male; Memory Disorders; Methionine; Middle Aged; Mutation; Phenotype; Positron-Emission Tomography; Presenilin-1 | 2010 |
Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2.
Topics: Adult; Atrophy; Brain; Brain Mapping; Cognition Disorders; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myotonic Dystrophy; Nerve Fibers, Myelinated; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Young Adult | 2010 |
Comparison of neuropsychological and FDG-PET findings between early- versus late-onset mild cognitive impairment: A five-year longitudinal study.
Topics: Age of Onset; Aged; Alzheimer Disease; Attention; Brain Chemistry; Cognition Disorders; Executive Function; Female; Fluorodeoxyglucose F18; Glucose; Humans; Language; Language Disorders; Logistic Models; Longitudinal Studies; Male; Memory; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Verbal Behavior | 2010 |
Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
Topics: Age of Onset; Aged; Aged, 80 and over; Binding, Competitive; Brain Mapping; Carbon Radioisotopes; Cerebral Cortex; Cerebrovascular Circulation; Cognition Disorders; Dementia; Early Diagnosis; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tetrabenazine | 2010 |
Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controls.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Area Under Curve; Brain; Cerebellum; Chromatography, High Pressure Liquid; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Thiazoles | 2010 |
Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at 3 years.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2010 |
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.
Topics: Alzheimer Disease; Biomarkers; Cognition Disorders; Diagnostic Imaging; Disease Progression; Fluorodeoxyglucose F18; Gene Expression Regulation; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Humans; Image Interpretation, Computer-Assisted; MicroRNAs; Monomeric Clathrin Assembly Proteins; Mutation; Phenotype; Radiopharmaceuticals | 2010 |
Executive and behavioral deficits share common neural substrates in frontotemporal lobar degeneration - a pilot FDG-PET study.
Topics: Aged; Behavioral Symptoms; Brain Mapping; Cognition Disorders; Executive Function; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Pilot Projects; Positron-Emission Tomography; Statistics as Topic | 2010 |
Deep brain stimulation of pedunculopontine tegmental nucleus (PPTg) promotes cognitive and metabolic changes: a target-specific effect or response to a low-frequency pattern of stimulation?
Topics: Aged; Cognition; Cognition Disorders; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Parkinson Disease; Pedunculopontine Tegmental Nucleus; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2010 |
Tarot decks and PET scans: predicting the future of MCI.
Topics: Alzheimer Disease; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2010 |
Comparing predictors of conversion and decline in mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; ROC Curve; Statistics, Nonparametric; tau Proteins; Time Factors | 2010 |
New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population.
Topics: Aged; Alzheimer Disease; Ambulatory Care Facilities; Amyloid beta-Peptides; Cognition Disorders; Data Interpretation, Statistical; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychometrics; Reproducibility of Results; tau Proteins | 2010 |
Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
Topics: Aged; Brain; Brain Mapping; Case-Control Studies; Cerebral Cortex; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography | 2010 |
Detection of early amnestic mild cognitive impairment without significantly objective memory impairment: a case-controlled study.
Topics: Aged; Amnesia; Analysis of Variance; Brain; Case-Control Studies; Cognition Disorders; Comorbidity; Female; Fluorodeoxyglucose F18; Geriatric Assessment; Humans; Male; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index | 2010 |
Cerebrospinal fluid tau protein levels and 18F-fluorodeoxyglucose positron emission tomography in the differential diagnosis of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Area Under Curve; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; tau Proteins | 2010 |
Unawareness of memory deficit in amnestic MCI: FDG-PET findings.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Awareness; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography | 2010 |
Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antidepressive Agents, Second-Generation; Brain Mapping; Cerebral Cortex; Citalopram; Cognition Disorders; Depression; Female; Fluorodeoxyglucose F18; Geriatrics; Glucose; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Reaction Time | 2011 |
Delineating cortical networks underlying epileptic encephalopathy and cognitive impairment with PET: a perspective.
Topics: Brain Diseases; Cerebral Cortex; Cognition Disorders; Epilepsy; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
18F-FDG PET reveals frontotemporal dysfunction in children with fever-induced refractory epileptic encephalopathy.
Topics: Brain Diseases; Cerebral Cortex; Child; Child, Preschool; Cognition Disorders; Electroencephalography; Epilepsy; Female; Fever; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Feature selection using factor analysis for Alzheimer's diagnosis using 18F-FDG PET images.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Diagnosis, Computer-Assisted; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Models, Statistical; Multivariate Analysis; Normal Distribution; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2010 |
Long-term epilepsy surgery outcomes in patients with MRI-negative temporal lobe epilepsy.
Topics: Adolescent; Adult; Anterior Temporal Lobectomy; Cognition Disorders; Dominance, Cerebral; Electrodes, Implanted; Electroencephalography; Epilepsy, Temporal Lobe; Female; Finland; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Signal Processing, Computer-Assisted; Temporal Lobe; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Wechsler Scales; Young Adult | 2010 |
Prefrontal and paralimbic metabolic dysregulation related to sustained attention in euthymic older adults with bipolar disorder.
Topics: Aged; Attention; Bipolar Disorder; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Limbic System; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prefrontal Cortex | 2010 |
Impact of EEG-vigilance on brain glucose uptake measured with [(18)F]FDG and PET in patients with depressive episode or mild cognitive impairment.
Topics: Adult; Aged; Arousal; Brain; Brain Mapping; Cognition Disorders; Depressive Disorder; Electroencephalography; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Signal Processing, Computer-Assisted | 2011 |
Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Status Schedule; Methionine; Middle Aged; Mutation; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Postmortem Changes; Presenilin-1; Statistics as Topic; Time Factors; Valine | 2011 |
Cognitive impairment and McArdle disease: Is there a link?
Topics: Aged; Brain; Cerebral Cortex; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glycogen Storage Disease Type V; Humans; Neuropsychological Tests; Positron-Emission Tomography | 2011 |
Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Benzothiazoles; Brain Mapping; Cerebral Cortex; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Oxygen; Positron-Emission Tomography; Statistics as Topic; Thiazoles | 2011 |
The neural substrates of script knowledge deficits as revealed by a PET study in Huntington's disease.
Topics: Adult; Basal Ganglia; Blood Glucose; Brain; Brain Mapping; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Frontal Lobe; Human Activities; Humans; Huntington Disease; Mental Processes; Middle Aged; Neostriatum; Neural Pathways; Positron-Emission Tomography; Reference Values; Serial Learning | 2011 |
Longitudinal change of biomarkers in cognitive decline.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Biomarkers; Cognition Disorders; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Outcome Assessment, Health Care; Peptide Fragments; Positron-Emission Tomography; Regression Analysis; Retrospective Studies | 2011 |
Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Mapping; Cerebral Cortex; Cognition Disorders; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Recall; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Registries; Severity of Illness Index | 2011 |
Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment.
Topics: Aged; Alzheimer Disease; Biomarkers; Calibration; Cognition; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Neurology; Neuropsychological Tests; Positron-Emission Tomography; Reproducibility of Results | 2011 |
Brain damage and IQ in unilateral Sturge-Weber syndrome: support for a "fresh start" hypothesis.
Topics: Adolescent; Brain; Brain Injuries; Brain Mapping; Child; Child, Preschool; Cognition Disorders; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Intelligence; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Seizures; Statistics, Nonparametric; Sturge-Weber Syndrome | 2011 |
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Apolipoprotein E3; Cognition Disorders; Disease Progression; Electroencephalography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Seizures | 2011 |
Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism.
Topics: Aged; Analysis of Variance; Brain Mapping; Case-Control Studies; Cerebral Cortex; Chi-Square Distribution; Cognition Disorders; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography | 2011 |
Relationship between occupation attributes and brain metabolism in frontotemporal dementia.
Topics: Aged; Brain; Brain Mapping; Cognition Disorders; Factor Analysis, Statistical; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Male; Mental Status Schedule; Middle Aged; Motor Activity; Neuropsychological Tests; Occupations; Photic Stimulation; Positron-Emission Tomography; Regression Analysis; Space Perception; Verbal Behavior | 2011 |
Stage-dependent agreement between cerebrospinal fluid proteins and FDG-PET findings in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Area Under Curve; Biomarkers; Cerebrospinal Fluid Proteins; Cognition Disorders; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Psychiatric Status Rating Scales; Retrospective Studies; Sensitivity and Specificity; tau Proteins | 2012 |
Dissociating behavioral disorders in early dementia-An FDG-PET study.
Topics: Aged; Analysis of Variance; Behavioral Symptoms; Brain; Brain Mapping; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Regression Analysis | 2011 |
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Benzoxazines; Cannabinoids; Choroid Plexus; Cognition Disorders; Corpus Striatum; Cyclooxygenase 2; Disease Models, Animal; Encephalitis; Enzyme-Linked Immunosorbent Assay; Fluorodeoxyglucose F18; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Mice; Mice, Transgenic; Microglia; Morpholines; Naphthalenes; Positron-Emission Tomography; Receptor, Cannabinoid, CB2; RNA, Messenger; Time Factors | 2012 |
Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain; Capillaries; Cognition Disorders; Cyclophosphamide; Doxorubicin; False Negative Reactions; Female; Fever; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Paresis; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Tissue Distribution; Tomography, X-Ray Computed; Vincristine | 2012 |
Longitudinal imaging pattern analysis (SPARE-CD index) detects early structural and functional changes before cognitive decline in healthy older adults.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Aniline Compounds; Brain; Brain Mapping; Cerebrovascular Circulation; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Statistics as Topic; Thiazoles | 2012 |
Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project.
Topics: Aged; Alzheimer Disease; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Rest | 2012 |
Shapes of the trajectories of 5 major biomarkers of Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Aniline Compounds; Apolipoprotein E4; Biomarkers; Cognition Disorders; Cohort Studies; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Immunoassay; Magnetic Resonance Imaging; Male; Mental Status Schedule; Nonlinear Dynamics; Peptide Fragments; Positron-Emission Tomography; tau Proteins; Thiazoles | 2012 |
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Brain; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Mental Status Schedule; National Institute on Aging (U.S.); Neuropsychological Tests; Positron-Emission Tomography; Thiazoles; United States | 2012 |
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Sensitivity and Specificity; Thiazoles | 2013 |
IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment.
Topics: Adrenal Cortex Hormones; Aged; Alzheimer Disease; Antibodies, Monoclonal, Murine-Derived; Atrophy; Autoimmunity; Biomarkers; Blotting, Western; Cognition Disorders; Cyclophosphamide; Disease Progression; Electrophysiology; Female; Fluorodeoxyglucose F18; Frontal Lobe; Hippocampus; Humans; Immunoglobulin A; Immunohistochemistry; Immunotherapy; Lewy Body Disease; Magnetic Resonance Imaging; Neurons; Plasma Exchange; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, N-Methyl-D-Aspartate; Rituximab; Synapses; Temporal Lobe; Treatment Outcome | 2012 |
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Chi-Square Distribution; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; National Institute on Aging (U.S.); Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Thiazoles; United States | 2012 |
Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Topics: Age of Onset; Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Apolipoproteins E; Brain Mapping; Carbon Radioisotopes; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Genotype; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2012 |
Multi-domain cognitive impairment disclosed before the diagnosis of chronic lymphocytic leukaemia: an autoimmune/paraneoplastic disorder?
Topics: Cognition Disorders; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Magnetic Resonance Imaging; Male; Middle Aged; Occipital Lobe; Positron-Emission Tomography | 2013 |
Acute cocaine induced deficits in cognitive performance in rhesus macaque monkeys treated with baclofen.
Topics: Animals; Baclofen; Brain; Cocaine; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; GABA-B Receptor Agonists; Injections, Intravenous; Macaca mulatta; Male; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals | 2013 |
Progressive neuropsychiatric and brain abnormalities after smoke inhalation.
Topics: Activities of Daily Living; Brain; Cognition Disorders; Depressive Disorder, Major; DNA Damage; Fluorodeoxyglucose F18; Fructose; Humans; Male; Memory, Long-Term; Methylphenidate; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Oxidative Stress; Positron-Emission Tomography; Radiopharmaceuticals; Sertraline; Smoke Inhalation Injury; Time Factors; Topiramate; Valproic Acid | 2012 |
Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer's disease.
Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Amyloid deposition, hypometabolism, and longitudinal cognitive decline.
Topics: Aged; Amyloid; Aniline Compounds; Body Burden; Cognition Disorders; Cognitive Dysfunction; Cross-Sectional Studies; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2012 |
Differential relations between fronto-limbic metabolism and executive function in patients with remitted bipolar I and bipolar II disorder.
Topics: Adult; Aged; Analysis of Variance; Bipolar Disorder; Brain Mapping; Case-Control Studies; Cognition Disorders; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Limbic System; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prefrontal Cortex; Statistics as Topic; Young Adult | 2012 |
Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cognition Disorders; Early Diagnosis; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Male; Memory; Memory Disorders; Positron-Emission Tomography; Prodromal Symptoms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tissue Distribution | 2012 |
Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Cerebellum; Cognition Disorders; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Gyrus Cinguli; Humans; Male; Middle Aged; Parietal Lobe; Positron-Emission Tomography; Prodromal Symptoms; Radiopharmaceuticals; Temporal Lobe | 2013 |
Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.
Topics: Aged; Alzheimer Disease; Area Under Curve; Biomarkers; Chi-Square Distribution; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Logistic Models; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Risk Factors | 2013 |
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognition Disorders; Databases, Factual; Disease Progression; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Sensitivity and Specificity; Statistics, Nonparametric; Time Factors | 2013 |
Clinical and biomarker investigation of a patient with a novel presenilin-1 mutation (A431V) in the mild cognitive impairment stage of Alzheimer's disease.
Topics: Alzheimer Disease; Cognition Disorders; Fluorodeoxyglucose F18; Genetic Markers; Glucose; Gyrus Cinguli; Humans; Male; Membrane Proteins; Middle Aged; Neuropsychological Tests; Point Mutation; Polymerase Chain Reaction; Presenilin-1; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed | 2002 |
Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cognition Disorders; Delusions; Female; Fluorodeoxyglucose F18; Frontal Lobe; Functional Laterality; Geriatric Assessment; Humans; Male; Psychiatric Status Rating Scales; Regression Analysis; Severity of Illness Index; Temporal Lobe; Tomography, Emission-Computed | 2003 |
A study of persistent post-concussion symptoms in mild head trauma using positron emission tomography.
Topics: Adult; Brain; Cognition Disorders; Craniocerebral Trauma; Female; Fluorodeoxyglucose F18; Humans; Injury Severity Score; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder.
Topics: Adult; Brain; Cognition Disorders; Corpus Striatum; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Neural Pathways; Neuropsychological Tests; Obsessive-Compulsive Disorder; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed | 2003 |
Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment.
Topics: Aged; Atrophy; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory; Memory Disorders; Middle Aged; Prospective Studies; Radiopharmaceuticals; Statistics as Topic; Tomography, Emission-Computed | 2003 |
A case of unilateral neglect in Huntington's disease.
Topics: Attention; Auditory Perception; Brain; Caudate Nucleus; Cognition Disorders; Electroencephalography; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Huntington Disease; Magnetic Resonance Imaging; Middle Aged; Perceptual Disorders; Radiopharmaceuticals; Tomography, Emission-Computed; Touch; Visual Perception | 2003 |
Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment.
Topics: Alzheimer Disease; Amnesia; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Limbic System; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed | 2003 |
Gender-specific differences of hypometabolism in mTLE: implication for cognitive impairments.
Topics: Adult; Blood Glucose; Cerebral Cortex; Cognition Disorders; Energy Metabolism; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Processing, Computer-Assisted; Male; Reference Values; Sclerosis; Sex Factors; Temporal Lobe; Tomography, Emission-Computed | 2003 |
Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence.
Topics: Adaptation, Physiological; Adult; Amphetamine-Related Disorders; Brain; Cognition Disorders; Corpus Striatum; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Male; Methamphetamine; Neuropsychological Tests; Presynaptic Terminals; Radiopharmaceuticals; Recovery of Function; Thalamus; Time Factors; Tomography, Emission-Computed | 2004 |
Subacute dementia and imaging correlates in a case of Fahr's disease.
Topics: Aggression; Anxiety; Basal Ganglia Diseases; Calcinosis; Cognition Disorders; Dementia; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Social Behavior; Syndrome; Tomography, Emission-Computed | 2004 |
Association of elevated phospho-tau levels with Alzheimer-typical 18F-fluoro-2-deoxy-D-glucose positron emission tomography findings in patients with mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Chemistry; Brain Mapping; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Phosphorylation; Predictive Value of Tests; Statistics, Nonparametric; tau Proteins; Tomography, Emission-Computed | 2004 |
MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.
Topics: Aged; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Brain; Cognition Disorders; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Male; Memory Disorders; Mental Recall; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Single-Blind Method | 2004 |
Anger and depression in cocaine addiction: association with the orbitofrontal cortex.
Topics: Adult; Anger; Chronic Disease; Cocaine-Related Disorders; Cognition Disorders; Depression; Disruptive, Impulse Control, and Conduct Disorders; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Inhibition, Psychological; Mental Disorders; MMPI; Personality Disorders; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals; Severity of Illness Index | 2005 |
FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Brain Concussion; Brain Mapping; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Memory; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Regression, Psychology; Reproducibility of Results; Time Factors | 2005 |
[The clinical utility of MR diffusion tensor imaging and spatially normalized PET to evaluate traumatic brain injury patients with memory and cognitive impairments].
Topics: Accidents, Traffic; Adult; Brain; Brain Injuries; Cognition Disorders; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Glucose; Humans; Male; Memory Disorders; Positron-Emission Tomography | 2005 |
Differences in regional brain metabolism associated with marijuana abuse in methamphetamine abusers.
Topics: Adult; Amphetamine-Related Disorders; Brain; Brain Mapping; Cognition Disorders; Drug Interactions; Drug Synergism; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Male; Marijuana Abuse; Methamphetamine; Positron-Emission Tomography; Temporal Lobe | 2005 |
Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index.
Topics: Aged; Brain; Brain Chemistry; Cerebrovascular Circulation; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 2005 |
Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Cohort Studies; Down-Regulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; Software Design | 2005 |
Reduced glucose metabolism in temporo-parietal cortices of women with borderline personality disorder.
Topics: Adult; Borderline Personality Disorder; Child; Child Abuse; Cognition Disorders; Dissociative Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Parietal Lobe; Positron-Emission Tomography; Radiopharmaceuticals; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Temporal Lobe; Wechsler Scales | 2005 |
Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Awareness; Caregivers; Cerebral Cortex; Cognition; Cognition Disorders; Energy Metabolism; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Middle Aged; Models, Neurological; Nerve Net; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Prefrontal Cortex; Self-Assessment; Surveys and Questionnaires | 2006 |
Frontal lobe hypometabolism and impaired insight in Alzheimer disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Awareness; Blood Glucose; Cognition Disorders; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Mental Status Schedule; Neuropsychological Tests; Positron-Emission Tomography; Psychometrics; Statistics as Topic | 2005 |
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.
Topics: Aged; Alzheimer Disease; Brain Mapping; Case-Control Studies; Cognition Disorders; Demography; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Psychological Tests; ROC Curve | 2005 |
Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Regression Analysis; Temporal Lobe | 2006 |
Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia.
Topics: Aged; Cognition Disorders; Dementia; Depression; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Inhibition, Psychological; Male; Neuropsychological Tests; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals; Severity of Illness Index; Temporal Lobe | 2006 |
Relationship between regional cerebral metabolism and consciousness disturbance in traumatic diffuse brain injury without large focal lesions: an FDG-PET study with statistical parametric mapping analysis.
Topics: Adult; Brain; Brain Injuries; Brain Mapping; Cognition Disorders; Consciousness Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index | 2006 |
Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Awareness; Brain; Cognition Disorders; Fluorodeoxyglucose F18; Functional Laterality; Genetic Predisposition to Disease; Genotype; Glucose; Health Status; Heterozygote; Humans; Longitudinal Studies; Memory Disorders; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Surveys and Questionnaires | 2006 |
Progression to dementia in clinical subtypes of mild cognitive impairment.
Topics: Aged; Amnesia; Brain Chemistry; Cognition Disorders; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Logistic Models; Male; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Radiopharmaceuticals; Thiazoles | 2006 |
Prefrontal hypofunction in patients with intractable mesial temporal lobe epilepsy.
Topics: Adult; Brain Mapping; Cognition Disorders; Energy Metabolism; Epilepsy; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Prefrontal Cortex; Set, Psychology | 2006 |
Metabolic brain networks associated with cognitive function in Parkinson's disease.
Topics: Brain; Cognition; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Metabolic Networks and Pathways; Middle Aged; Nerve Net; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Principal Component Analysis; Reproducibility of Results | 2007 |
PET of brain amyloid and tau in mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Case-Control Studies; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurofibrillary Tangles; Nitriles; Plaque, Amyloid; Positron-Emission Tomography; tau Proteins | 2006 |
Non-fluent progressive aphasia: cerebral metabolic patterns and brain reserve.
Topics: Age Distribution; Aged; Aged, 80 and over; Aphasia, Primary Progressive; Brain; Brain Mapping; Cognition Disorders; Educational Status; Energy Metabolism; Female; Fluorodeoxyglucose F18; Frontal Lobe; Functional Laterality; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Sex Distribution; Temporal Lobe | 2007 |
Hippocampal hypometabolism predicts cognitive decline from normal aging.
Topics: Aged; Aged, 80 and over; Aging; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Glucose Metabolism Disorders; Hippocampus; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic | 2008 |
Prefrontal cortex dysfunction and depression in atypical parkinsonian syndromes.
Topics: Aged; Brain Stem; Cerebellum; Cognition Disorders; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Neuropsychological Tests; Parietal Lobe; Parkinsonian Disorders; Pilot Projects; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals; Severity of Illness Index; Thalamus; Tomography, X-Ray Computed | 2007 |
Where the brain grows old: decline in anterior cingulate and medial prefrontal function with normal aging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Cognition; Cognition Disorders; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Male; Middle Aged; Prefrontal Cortex; Radiopharmaceuticals | 2007 |
Metabolic correlates of executive dysfunction. Different patterns in mild and very mild Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Problem Solving; Statistics as Topic | 2007 |
Male gender is associated with greater cerebral hypometabolism in frontotemporal dementia: evidence for sex-related cognitive reserve.
Topics: Aged; Brain; Brain Mapping; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Psychiatric Status Rating Scales; Radiopharmaceuticals; Sex Characteristics | 2007 |
PET imaging of amyloid deposition in patients with mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Cerebral Cortex; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Thiazoles | 2008 |
Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cerebral Cortex; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Frontal Lobe; Functional Laterality; Glucose; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Severity of Illness Index; Temporal Lobe; Tissue Distribution | 2007 |
FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment.
Topics: Aged; Biomarkers; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Longitudinal Studies; Male; Mental Status Schedule; Positron-Emission Tomography; Prognosis; Psychiatric Status Rating Scales; Severity of Illness Index; Stereotaxic Techniques; tau Proteins | 2007 |
Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Brain; Cognition Disorders; Disease Progression; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gyrus Cinguli; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Statistics as Topic; Temporal Lobe | 2007 |
Cognitive deficits during status epilepticus and time course of recovery: a case report.
Topics: Adult; Anticonvulsants; Cognition Disorders; Delta Rhythm; Electroencephalography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Frontal Lobe; Humans; Neural Inhibition; Neural Pathways; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Status Epilepticus; Time Factors; Treatment Outcome | 2007 |
FDG-PET in never-previously medicated psychotic adolescents treated with olanzapine or haloperidol.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Frontal Lobe; Haloperidol; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Occipital Lobe; Olanzapine; Positron-Emission Tomography; Psychotic Disorders; Radiopharmaceuticals; Temporal Lobe | 2007 |
Statistical image analysis of cerebral glucose metabolism in patients with cognitive impairment following diffuse traumatic brain injury.
Topics: Adult; Brain Injuries; Brain Mapping; Cerebellum; Cerebral Cortex; Cognition Disorders; Disability Evaluation; Down-Regulation; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Intelligence; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Temporal Lobe; Thalamus | 2007 |
What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Neurologic Examination; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2007 |
Corticobasal syndrome associated with the A9D Progranulin mutation.
Topics: Alleles; Apraxias; Brain; Cognition Disorders; Dementia; DNA; DNA-Binding Proteins; Fluorodeoxyglucose F18; Humans; Intercellular Signaling Peptides and Proteins; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Progranulins; Reverse Transcriptase Polymerase Chain Reaction; Syndrome | 2007 |
Cerebral glucose metabolism in dizygotic twin pairs discordant for Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neuropsychological Tests; Registries; Surveys and Questionnaires; Twins, Dizygotic | 2008 |
Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates.
Topics: Administration, Intranasal; Analysis of Variance; Animals; Behavior, Animal; Brain Mapping; Cerebral Cortex; Cognition Disorders; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Glucose; Injections, Intravenous; Intracellular Signaling Peptides and Proteins; Macaca mulatta; Male; Neuropeptides; Orexins; Positron-Emission Tomography; Psychomotor Performance; Sleep Deprivation; Sympathomimetics; Task Performance and Analysis | 2007 |
Diagnostic accuracy of consensus diagnostic criteria for frontotemporal dementia in a memory clinic population.
Topics: Aged; Aged, 80 and over; Ambulatory Care Facilities; Brain; Cognition Disorders; Consensus; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Patient Care Team; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Severity of Illness Index; Surveys and Questionnaires; Tomography, Emission-Computed, Single-Photon | 2008 |
Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.
Topics: Aged; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Neuropsychological Tests; Parkinson Disease, Secondary; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors | 2008 |
18F-FDG PET in neurodegenerative Langerhans cell histiocytosis : results and potential interest for an early diagnosis of the disease.
Topics: Adolescent; Adult; Aged; Brain; Brain Mapping; Cerebellar Ataxia; Cognition Disorders; Diagnosis, Differential; Early Diagnosis; Female; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Male; Middle Aged; Motor Neuron Disease; Neurodegenerative Diseases; Positron-Emission Tomography; Predictive Value of Tests; Prognosis | 2008 |
Right prefrontal hypometabolism predicts delusions in dementia with Lewy bodies.
Topics: Aged; Cognition Disorders; Delusions; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Hallucinations; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prefrontal Cortex; Regression Analysis; Sensitivity and Specificity | 2009 |
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Dementia; Europe; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; United States | 2008 |
Disruption of temporal processing in a subject with probable frontotemporal dementia.
Topics: Attention; Auditory Perception; Biological Clocks; Cognition Disorders; Control Groups; Dementia; Female; Fluorodeoxyglucose F18; Frontal Lobe; Functional Laterality; Humans; Judgment; Memory; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prefrontal Cortex; Reaction Time; Temporal Lobe; Time Perception; Visual Perception | 2008 |
Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Brain; Case-Control Studies; Cognition Disorders; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Wechsler Adult Intelligence Scale performance. Cortical localization by fluorodeoxyglucose F 18-positron emission tomography.
Topics: Aged; Brain; Cerebral Cortex; Cognition Disorders; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Intelligence; Male; Middle Aged; Radiography; Tomography, Emission-Computed; Wechsler Scales | 1984 |
Cognitive and cerebral metabolic function in early and advanced Alzheimer's disease.
Topics: Alzheimer Disease; Blood Glucose; Cerebral Cortex; Cognition Disorders; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Psychometrics; Tomography, Emission-Computed; Wechsler Scales | 1984 |
Metabolic and cognitive changes in hereditary ataxia.
Topics: Adult; Brain Chemistry; Cognition Disorders; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Olivopontocerebellar Atrophies; Psychiatric Status Rating Scales; Risk; Tomography, Emission-Computed | 1993 |
Left and right hemisphere contribution to recovery from neglect after right hemisphere damage--an [18F]FDG pet study of two cases.
Topics: Aged; Brain; Brain Chemistry; Brain Diseases; Cerebrovascular Disorders; Cognition Disorders; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Functional Laterality; Humans; Male; Psychomotor Performance; Radiography; Tomography, Emission-Computed | 1993 |
Regional cerebral glucose metabolism in children with deterioration of one or more cognitive functions and continuous spike-and-wave discharges during sleep.
Topics: Aphasia; Brain; Child; Child, Preschool; Cognition Disorders; Deoxyglucose; Electroencephalography; Epilepsy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neuropsychological Tests; Retrospective Studies; Sleep; Tissue Distribution; Tomography, Emission-Computed | 1995 |
Positron emission tomography in children with neurofibromatosis-1.
Topics: Adolescent; Adult; Brain; Case-Control Studies; Cerebral Cortex; Child; Child, Preschool; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neurofibromatosis 1; Neuropsychological Tests; Radiopharmaceuticals; Thalamus; Tomography, Emission-Computed | 1997 |
Prefrontal asymmetric interictal glucose hypometabolism and cognitive impairment in patients with temporal lobe epilepsy.
Topics: Adult; Brain; Cognition Disorders; Educational Status; Electroencephalography; Epilepsy, Temporal Lobe; Fluorodeoxyglucose F18; Functional Laterality; Humans; Intelligence; Intelligence Tests; Male; Multivariate Analysis; Neuropsychological Tests; Prefrontal Cortex; Radiography; Speech; Tomography, Emission-Computed; Wechsler Scales | 1997 |
Idiopathic rolandic epilepsy with "interictal" facial myoclonia and oromotor deficit: a longitudinal EEG and PET study.
Topics: Brain; Child, Preschool; Cognition Disorders; Comorbidity; Electroencephalography; Epilepsy, Rolandic; Facial Muscles; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Longitudinal Studies; Myoclonus; Neuropsychological Tests; Sleep; Tomography, Emission-Computed | 1999 |
Neuroimaging and behavioral correlates of recovery from mnestic block syndrome and other cognitive deteriorations.
Topics: Amnesia; Blood Glucose; Brain Mapping; Cerebral Cortex; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intelligence; Magnetic Resonance Imaging; Male; Mental Recall; Neuropsychological Tests; Stress Disorders, Post-Traumatic; Tomography, Emission-Computed | 2000 |
Method to correlate 1H MRSI and 18FDG-PET.
Topics: Aged; Algorithms; Analysis of Variance; Aspartic Acid; Brain; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Spectroscopy; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed | 2000 |
Anterior choroidal artery infarction presenting as a progressive cognitive deficit.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebral Infarction; Cerebrovascular Circulation; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 2000 |
Correlation of intellectual impairment in Parkinson's disease with FDG PET scan.
Topics: Aged; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Image Processing, Computer-Assisted; Intelligence; Male; Memory; Mental Status Schedule; Middle Aged; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity.
Topics: Adult; Arousal; Brain; Cognition Disorders; Disorders of Excessive Somnolence; Electrocardiography; Fluorodeoxyglucose F18; Humans; Male; Nerve Net; Polysomnography; Radiopharmaceuticals; Regional Blood Flow; Sleep Deprivation; Sleep, REM; Synapses; Thalamus; Time Factors; Tomography, Emission-Computed; Wakefulness | 2000 |
Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).
Topics: Aged; Aged, 80 and over; Apolipoproteins E; Brain; Cognition Disorders; Entorhinal Cortex; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Predictive Value of Tests; Radiography; Tomography, Emission-Computed | 2001 |
Cerebral metabolism, anatomy, and cognition in monozygotic twins discordant for dementia of the Alzheimer type.
Topics: Alzheimer Disease; Brain; Cognition Disorders; Deoxyglucose; Diseases in Twins; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed; Tomography, X-Ray Computed; Twins, Monozygotic | 1987 |